<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">92523</article-id><article-id pub-id-type="doi">10.7554/eLife.92523</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>RNA fusion in human retinal development</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-297920"><name><surname>Wang</surname><given-names>Wen</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8601-7385</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-297921"><name><surname>Zhang</surname><given-names>Xiao</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8599-3181</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-297922"><name><surname>Zhao</surname><given-names>Ning</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-297923"><name><surname>Xu</surname><given-names>Ze-Hua</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-127978"><name><surname>Jin</surname><given-names>Kangxin</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0108-6948</contrib-id><email>jinkx@mail.ccmu.edu.cn</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-217496"><name><surname>Jin</surname><given-names>Zi-Bing</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0515-698X</contrib-id><email>jinzb502@ccmu.edu.cn</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/013xs5b60</institution-id><institution>Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University</institution></institution-wrap><addr-line><named-content content-type="city">Beijing</named-content></addr-line><country>China</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Sappington</surname><given-names>Rebecca M</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04v8djg66</institution-id><institution>Wake Forest Baptist Medical Center</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Smith</surname><given-names>Lois EH</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00dvg7y05</institution-id><institution>Boston Children's Hospital</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>02</day><month>01</month><year>2024</year></pub-date><pub-date pub-type="collection"><year>2024</year></pub-date><volume>13</volume><elocation-id>e92523</elocation-id><history><date date-type="received" iso-8601-date="2023-09-05"><day>05</day><month>09</month><year>2023</year></date><date date-type="accepted" iso-8601-date="2023-12-14"><day>14</day><month>12</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2022-11-10"><day>10</day><month>11</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.11.10.515982"/></event></pub-history><permissions><copyright-statement>© 2024, Wang, Zhang et al</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Wang, Zhang et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-92523-v3.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-92523-figures-v3.pdf"/><abstract><p>Chimeric RNAs have been found in both cancerous and healthy human cells. They have regulatory effects on human stem/progenitor cell differentiation, stemness maintenance, and central nervous system development. However, whether they are present in human retinal cells and their physiological functions in the retinal development remain unknown. Based on the human embryonic stem cell-derived retinal organoids (ROs) spanning from days 0 to 120, we present the expression atlas of chimeric RNAs throughout the developing ROs. We confirmed the existence of some common chimeric RNAs and also discovered many novel chimeric RNAs during retinal development. We focused on <italic>CTNNBIP1-CLSTN1</italic> (<italic>CTCL</italic>) whose downregulation caused precocious neuronal differentiation and a marked reduction of neural progenitors in human cerebral organoids. <italic>CTCL</italic> is universally present in human retinas, ROs, and retinal cell lines, and its loss-of-function biases the progenitor cells toward retinal pigment epithelial cell fate at the expense of retinal cells. Together, this work provides a landscape of chimeric RNAs and reveals evidence for their critical role in human retinal development.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>human</kwd><kwd>retinal development</kwd><kwd>transcriptome</kwd><kwd>chimeric RNA</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>82125007</award-id><principal-award-recipient><name><surname>Jin</surname><given-names>Zi-Bing</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection, and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Chimeric RNAs are widely distributed spatiotemporally during human retinal development and have important regulatory functions, such as silencing of CTNNBIP1-CLSTN1 biasing the progenitor cells toward the RPE cell fate at the expense of neural retinal cell fates.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The human retina is a laminar structure with a large number of different component cells that form morphologically and functionally distinct circuits. They work in parallel and in combination to produce complex visual output (<xref ref-type="bibr" rid="bib8">Hoon et al., 2014</xref>). During retinogenesis, different subtypes of neurons are generated from the same group of retinal progenitor cells (RPCs) and precisely self-assemble into a functionally mature retina (<xref ref-type="bibr" rid="bib29">Masland, 2012</xref>).</p><p>Dissecting the molecular mechanisms of human retinogenesis and functional maintenance has always been a focus and a challenging issue, which is particularly important for the treatment of human retinal diseases such as macular degeneration. A few groups have systematically elucidated the transcriptomics, chromatin accessibility, and proteomic dynamics during human and mouse retinogenesis (<xref ref-type="bibr" rid="bib10">Huang et al., 2023</xref>), and comprehensively described the similarities and differences during this process. Lu et al. identified an unexpected role for <italic>ATOH7</italic> expression in the regulation of photoreceptor specification during late retinogenesis as well as the enriched bivalent modification of H3K4me3 and H3K27me3 in human but not in murine retinogenesis (<xref ref-type="bibr" rid="bib26">Lu et al., 2020</xref>), further underscoring the limitations of using mouse models to study the human retina and transcriptional regulation in human retinogenesis.</p><p>Difficulties in obtaining normal human retinal tissue have hampered studies of human retinal development. The emergence of retinal organoids (ROs) could circumvent this problem (<xref ref-type="bibr" rid="bib1">Cheng et al., 2023</xref>; <xref ref-type="bibr" rid="bib11">Jin et al., 2019</xref>). Many groups have used ROs to conduct studies related to human retinal development and have solved a basket of previously unsolvable problems, confirming the high similarity between ROs and human retina in terms of molecular features, cell types, and developmental rates (<xref ref-type="bibr" rid="bib3">Cowan et al., 2020</xref>; <xref ref-type="bibr" rid="bib26">Lu et al., 2020</xref>; <xref ref-type="bibr" rid="bib50">Xie et al., 2020</xref>). Our group has extensive experience in RO culture and has conducted a series of studies using ROs (<xref ref-type="bibr" rid="bib5">Deng et al., 2018</xref>; <xref ref-type="bibr" rid="bib27">Ma et al., 2022</xref>; <xref ref-type="bibr" rid="bib37">Pan et al., 2020</xref>; <xref ref-type="bibr" rid="bib53">Zhang et al., 2021</xref>). For example, together with other groups, we have used ROs to confirm that retinoblastoma tumor cells are derived from cone precursor cells (<xref ref-type="bibr" rid="bib2">Clevers, 2016</xref>; <xref ref-type="bibr" rid="bib11">Jin et al., 2019</xref>; <xref ref-type="bibr" rid="bib20">Li et al., 2022</xref>; <xref ref-type="bibr" rid="bib24">Liu et al., 2021</xref>; <xref ref-type="bibr" rid="bib23">Liu et al., 2020</xref>).</p><p>Chimeric RNAs are the ligation products of two or even more DNA or RNA sequences before or after transcription. They can be further translated into proteins in addition to their RNA form, increasing the richness of the transcriptome and proteome. Previous studies of chimeric RNAs have focused on tumors and larger tissues and organs, and found that chimeric RNAs are widely present in human normal and tumor tissues as part of the transcriptome and can regulate the activities of individual cells (<xref ref-type="bibr" rid="bib6">Elfman and Li, 2018</xref>; <xref ref-type="bibr" rid="bib9">Hu et al., 2018</xref>; <xref ref-type="bibr" rid="bib31">Mertens et al., 2015</xref>; <xref ref-type="bibr" rid="bib41">Singh et al., 2020</xref>). It has been shown that chimeric RNAs in normal human cortex increase with age and show differences in individual cells and tissues (<xref ref-type="bibr" rid="bib30">Mehani et al., 2020</xref>), highlighting the critical role of chimeric RNAs in central nervous system (CNS) development and cell lineage maintenance. In 2021, Luo’s group found that downregulation of <italic>CTNNBIP1-CLSTN1</italic> (<italic>CTCL</italic>) affects the growth of cerebral organoids, causing premature neuronal differentiation, and a marked reduction of neural progenitors (<xref ref-type="bibr" rid="bib36">Ou et al., 2021</xref>). As retina is a part of the CNS, we hypothesize that <italic>CTCL</italic> is also present in the retina and plays an important role in human retinal development.</p><p>This study aims to investigate the molecular mechanism of human retinal development and function maintenance from a new perspective of chimeric RNAs. We used human embryonic stem cell (hESC)-derived ROs and performed RNA sequencing. We found that chimeric RNAs were expressed at all stages of RO development. Chimeric RNA <italic>CTCL</italic> is widely expressed in the human retina but not in the murine retina, and is critical for the differentiation of RPCs into neural retina (NR) or retinal pigment epithelium (RPE). RPCs with a relatively high level of <italic>CTCL</italic> expression will differentiate into NR, while those with a relatively low level of <italic>CTCL</italic> will differentiate toward RPE. These results provide important evidence for the physiological function of chimeric RNAs in human retinogenesis.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Chimeric RNAs are present throughout the retinogenesis</title><p>To explore the chimeric RNAs in the developing human retina, we cultured ROs according to the methods described previously (<xref ref-type="bibr" rid="bib14">Kim et al., 2019</xref>; <xref ref-type="bibr" rid="bib25">Lowe et al., 2016</xref>). On day 0 (D0) of differentiation, hESCs in a good growth state were dissociated into individual cells and seeded at a certain cell density in V-shaped low-adhesion culture dishes so that the cells would aggregate into clusters to induce the neuroepithelial formation. At D30 of differentiation, the RO outermost layer with translucent NR structures was visible. As the differentiation time prolonged, the NR gradually became denser. At D105 of differentiation, ROs could be seen with the formation of RPE. At D120 of differentiation, the outer segments of photoreceptor cells were seen on the surface of ROs. We collected organoids from 0 to 120 days for RNA sequencing (<xref ref-type="fig" rid="fig1">Figure 1</xref>, top and middle panels). Using FusionCatcher software, we examined chimeric RNAs in human ROs covering eight developmental stages from D0, 30, 45, 60, 75, 90, and 105–120, corresponding to in vivo developmental stages D0, 30, 45, 60, 75, 90, 105, and 120 (<xref ref-type="bibr" rid="bib3">Cowan et al., 2020</xref>), respectively. Each stage included two to three biological replicates (a total of <italic>N</italic> = 22), and each replicate contained approximately 100 ROs. To reduce false positives, splicing events were considered as positive chimeric RNA candidates only if spanning unique reads were detected at least once (<xref ref-type="fig" rid="fig1">Figure 1</xref>, bottom panel).</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>The general scheme of detection of chimeric RNAs.</title><p>(Top panel) Procedure for the generation of human retinal organoids (ROs) from pluripotent stem cells. (Middle panel) D0–120 human ROs were used for bulk RNA sequencing. Scale bars: 200 μm (D0) and 400 μm (D30–D120). (Bottom panel) Illustration of chimeric RNA screening process and criteria by FusionCatcher.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92523-fig1-v3.tif"/></fig><p>Chimeric RNAs were continuously expressed during RO development (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Chimeric events were categorized according to the locations of the parental genes on the chromosome, either inter- or intra-chromosomal. While the number of intra-chromosomal chimeric RNAs increased with the development of ROs (<italic>r</italic><sup>2</sup> = 0.93, p = 0.00076, Pearson’s correlation analysis), there was no such trend for inter-chromosomal chimeric RNAs (<xref ref-type="fig" rid="fig2">Figure 2B,C</xref>). Chimeric events can also be categorized according to the predicted effect (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). In the top three categories, the number of ‘In-frame’ chimeric RNAs was 11.2%, followed by ‘CDS(truncated)_UTR’ (10.7%) and ‘UTR_UTR’ (10.7%) (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). We further classified chimeric events according to the type of their parental genes. The majority of chimeric RNAs were formed between two protein-coding genes (61.9%) (<xref ref-type="fig" rid="fig3">Figure 3B</xref>).</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Expression of chimeric RNAs in the developing human retinal organoids.</title><p>(<bold>A</bold>) Circos plots of genomic distribution of chimeric RNA parental genes observed in this work. Red lines indicate parental genes located in the same chromosome. Blue lines indicate parental genes located in different chromosomes. The outermost colored lines of circos plots represent chromosomes. (<bold>B</bold>) Types of chimeric RNAs based on parental genes’ genomic distribution. (<bold>C</bold>) Pearson’s correlation analysis of the number of chimeric RNAs and developmental stages.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92523-fig2-v3.tif"/></fig><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Characterization of chimeric RNAs in the developing human retinal organoids.</title><p>(<bold>A</bold>) Top 14 types and corresponding numbers of chimeric RNAs based on predicted effects. (<bold>B</bold>) Biotype quantification of parental gene combinations in all samples. TunpP: transcribed unprocessed pseudogene; TuniP: transcribed unitary pseudogene. (<bold>C</bold>) Motifs consisting of 20 bp DNA sequences around the fusion site. (<bold>D</bold>) Spearman correlation analysis of expression level of chimeric RNAs and their parental genes, p &gt; 0.05.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92523-fig3-v3.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Types of chimeric RNAs based on predicted effect.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92523-fig3-figsupp1-v3.tif"/></fig></fig-group><p>Next, we examined the motifs covering 10 bp sequences immediately upstream or downstream of the fusion site of parental genes and found that the canonical AG/GT donor–acceptor motif had the highest position weight (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). In addition, we also found that the expression of the chimeric RNAs did not correlate with the expression of the parental genes (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). These results were consistent with previous reports (<xref ref-type="bibr" rid="bib36">Ou et al., 2021</xref>; <xref ref-type="bibr" rid="bib41">Singh et al., 2020</xref>), indicating that the procedure for screening chimeric RNAs was reliable and that these chimeric RNAs do not arise randomly, suggesting that they may play a role in the normal development and physiological activity of the retina.</p></sec><sec id="s2-2"><title><italic>CTCL</italic> is present in the human retina and at all the stages of RO development</title><p><italic>CTCL</italic> has been shown to have a regulatory role in human cerebral development. Similarly, four isoforms of <italic>CTCL</italic>, joined by alternative splicing of the parent pre-mRNAs, were detected in the ROs by RNA-seq. In-frame <italic>CTCL</italic> can be further translated into chimeric proteins, and we think that it plays a more critical role than the other three isoforms. It was dynamically expressed during RO development and there were two obvious higher expression timepoints at D60 and D120 (<xref ref-type="fig" rid="fig4">Figure 4A, B</xref>). Retinal cells like cones, rods, and horizonal cells had been generated around D120, so we chose D60 when most retinal cells were progenitors. To further validate the presence of <italic>CTCL</italic> in the developing human ROs, we extracted total RNAs from D60 human ROs, followed by reverse transcription and Sanger sequencing using specific primers to amplify the fragments containing fusion sites between <italic>CTNNBIP1</italic> and <italic>CLSTN1</italic> (<xref ref-type="supplementary-material" rid="fig4sdata1">Figure 4—source data 1</xref>; <xref ref-type="supplementary-material" rid="fig4sdata2">Figure 4—source data 2</xref>; <xref ref-type="fig" rid="fig4">Figure 4C,D</xref> and Key resources table). At D60, the In-frame, UTR_CDS(truncated)-1, and CDS(truncated)Intronic <italic>CTCL</italic> isoforms were confirmed but UTR_CDS(truncated)-2 <italic>CTCL</italic> was not detected.</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Four isoforms of <italic>CTCL</italic> are present in the retinal organoids (ROs).</title><p>(<bold>A</bold>) Heatmap of <italic>CTCL</italic>’s spanning unique reads of each isoform in the indicated stages. UTR_CDS(TR)-1: UTR_CDS(truncated)-1; CDS(TR)Intronic: CDS(truncated)Intronic; UTR_CDS(TR)-2: UTR_CDS(truncated)-2. (<bold>B</bold>) Schematic diagram of the structures of the four isoforms of <italic>CTCL</italic>. Blue represents upstream parental gene, red represents downstream parental gene. (<bold>C</bold>) Four isoforms of <italic>CTC</italic>L in D60 ROs were validated by quantitative reverse transcription polymerase chain reaction (qRT-PCR). (<bold>D</bold>) Sanger sequencing to verify three isoforms of <italic>CTCL</italic>.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig4">Figure 4C</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-92523-fig4-data1-v3.pdf"/></supplementary-material></p><p><supplementary-material id="fig4sdata2"><label>Figure 4—source data 2.</label><caption><title>Source data for <xref ref-type="fig" rid="fig4">Figure 4C</xref> (labelled).</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-92523-fig4-data2-v3.pdf"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92523-fig4-v3.tif"/></fig><p>To further validate the widespread presence of the In-frame <italic>CTCL</italic> in vivo and in vitro, we examined it in various samples including mouse retinas, three human induced pluripotent stem cell (iPSC)-cultured ROs, and human retinas. Indeed, the In-frame <italic>CTCL</italic> was consistently identified in human retinas, iPSCs1/iPSCs2/iPSCs3-derived ROs, and H9 cells, but not in the mouse retinas (<xref ref-type="supplementary-material" rid="fig5sdata1">Figure 5—source data 1</xref>; <xref ref-type="supplementary-material" rid="fig5sdata2">Figure 5—source data 2</xref>; <xref ref-type="supplementary-material" rid="fig5sdata3">Figure 5—source data 3</xref>; <xref ref-type="supplementary-material" rid="fig5sdata4">Figure 5—source data 4</xref>; <xref ref-type="fig" rid="fig5">Figure 5</xref>). Moreover, we also screened <italic>CTCL</italic> using the retinal transcriptome sequencing data available in the Gene Expression Omnibus (GEO) database, all of the nine human retinal samples yielded uniformly positive results (<xref ref-type="table" rid="table1">Table 1</xref>; <xref ref-type="bibr" rid="bib44">Sun et al., 2019</xref>; <xref ref-type="bibr" rid="bib52">Zauhar et al., 2022</xref>). These results suggest that <italic>CTCL</italic> is universally generated in human retinas in vivo, ROs, and retinal cell lines in vitro, but not a phenomenon of the H9 cell line exclusively. The dynamic presence of <italic>CTCL</italic>, especially the In-frame isoform, suggests that it may play a vital role in human retinal development.</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>In-frame <italic>CTCL</italic> is common in human retinas and retinal organoids (ROs).</title><p>(<bold>A</bold>) The qRT-PCR validation of the In-frame <italic>CTCL</italic> in the mouse retina, iPSCs1/iPSCs2-derived ROs, and H9 cells. (<bold>B</bold>) The qRT-PCR validation of In-frame <italic>CTCL</italic> in the iPSCs3-derived ROs and human retina. (<bold>C</bold>) Verification of the In-frame <italic>CTCL</italic> in the mouse retina, iPSCs1/iPSCs2-derived ROs and H9 cells by Sanger sequencing. (<bold>D</bold>) Verification of the In-frame <italic>CTCL</italic> in the iPSCs3-derived ROs and human retinas by Sanger sequencing.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig5">Figure 5A</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-92523-fig5-data1-v3.pdf"/></supplementary-material></p><p><supplementary-material id="fig5sdata2"><label>Figure 5—source data 2.</label><caption><title>Source data for <xref ref-type="fig" rid="fig5">Figure 5A</xref> (labelled).</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-92523-fig5-data2-v3.pdf"/></supplementary-material></p><p><supplementary-material id="fig5sdata3"><label>Figure 5—source data 3.</label><caption><title>Source data for <xref ref-type="fig" rid="fig5">Figure 5B</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-92523-fig5-data3-v3.pdf"/></supplementary-material></p><p><supplementary-material id="fig5sdata4"><label>Figure 5—source data 4.</label><caption><title>Source data for <xref ref-type="fig" rid="fig5">Figure 5B</xref> (labelled).</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-92523-fig5-data4-v3.pdf"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92523-fig5-v3.tif"/></fig><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title><italic>CTCL</italic> is detected in multiple healthy human retinas by RNA-seq.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Data source</th><th align="left" valign="bottom">Samples</th><th align="left" valign="bottom">Gene 1 symbol</th><th align="left" valign="bottom">Gene 2 symbol</th><th align="left" valign="bottom">Fusion point for gene 1</th><th align="left" valign="bottom">Fusion point for gene 2</th></tr></thead><tbody><tr><td align="left" valign="bottom">PMID: 30874468 (<xref ref-type="bibr" rid="bib44">Sun et al., 2019</xref>) Data published by our lab</td><td align="left" valign="bottom">Human retina</td><td align="left" valign="bottom"><italic>CTNNBIP1</italic></td><td align="left" valign="bottom"><italic>CLSTN1</italic></td><td align="left" valign="bottom">1:9871187:-</td><td align="left" valign="bottom">1:9773394:-</td></tr><tr><td align="left" valign="bottom">PMID: 30874468 (<xref ref-type="bibr" rid="bib44">Sun et al., 2019</xref>)<break/>Data published by our lab</td><td align="left" valign="bottom">Human retina</td><td align="left" valign="bottom"><italic>CTNNBIP1</italic></td><td align="left" valign="bottom"><italic>CLSTN1</italic></td><td align="left" valign="bottom">1:9871187:-</td><td align="left" valign="bottom">1:9773394:-</td></tr><tr><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/35784369">PMID:</ext-link>35784369<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/35784369"> </ext-link>(<xref ref-type="bibr" rid="bib52">Zauhar et al., 2022</xref>)<break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/35784369">SRR22315404</ext-link></td><td align="left" valign="bottom">Human retina</td><td align="left" valign="bottom"><italic>CTNNBIP1</italic></td><td align="left" valign="bottom"><italic>CLSTN1</italic></td><td align="left" valign="bottom">1:9871187:-</td><td align="left" valign="bottom">1:9773394:-</td></tr><tr><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/35784369">PMID:</ext-link>35784369<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/35784369"> </ext-link>(<xref ref-type="bibr" rid="bib52">Zauhar et al., 2022</xref>)<break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/35784369">SRR22315407</ext-link></td><td align="left" valign="bottom">Human retina</td><td align="left" valign="bottom"><italic>CTNNBIP1</italic></td><td align="left" valign="bottom"><italic>CLSTN1</italic></td><td align="left" valign="bottom">1:9871187:-</td><td align="left" valign="bottom">1:9773394:-</td></tr><tr><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/35784369">PMID:</ext-link>35784369<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/35784369"> </ext-link>(<xref ref-type="bibr" rid="bib52">Zauhar et al., 2022</xref>)<break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/35784369">SRR22315408</ext-link></td><td align="left" valign="bottom">Human retina</td><td align="left" valign="bottom"><italic>CTNNBIP1</italic></td><td align="left" valign="bottom"><italic>CLSTN1</italic></td><td align="left" valign="bottom">1:9871187:-</td><td align="left" valign="bottom">1:9773394:-</td></tr><tr><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/35784369">PMID:</ext-link>35784369<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/35784369"> </ext-link>(<xref ref-type="bibr" rid="bib52">Zauhar et al., 2022</xref>)<break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/35784369">SRR22315412</ext-link></td><td align="left" valign="bottom">Human retina</td><td align="left" valign="bottom"><italic>CTNNBIP1</italic></td><td align="left" valign="bottom"><italic>CLSTN1</italic></td><td align="left" valign="bottom">1:9871187:-</td><td align="left" valign="bottom">1:9773394:-</td></tr><tr><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/35784369">PMID:</ext-link>35784369<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/35784369"> </ext-link>(<xref ref-type="bibr" rid="bib52">Zauhar et al., 2022</xref>)<break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/35784369">SRR22315419</ext-link></td><td align="left" valign="bottom">Human retina</td><td align="left" valign="bottom"><italic>CTNNBIP1</italic></td><td align="left" valign="bottom"><italic>CLSTN1</italic></td><td align="left" valign="bottom">1:9871187:-</td><td align="left" valign="bottom">1:9773394:-</td></tr><tr><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/35784369">PMID:</ext-link><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/35784369">35784369</ext-link><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/35784369"> </ext-link>(<xref ref-type="bibr" rid="bib52">Zauhar et al., 2022</xref>)<break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/35784369">SRR22315420</ext-link></td><td align="left" valign="bottom">Human retina</td><td align="left" valign="bottom"><italic>CTNNBIP1</italic></td><td align="left" valign="bottom"><italic>CLSTN1</italic></td><td align="left" valign="bottom">1:9871187:-</td><td align="left" valign="bottom">1:9773394:-</td></tr><tr><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/35784369">PMID:</ext-link><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/35784369">35784369</ext-link><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/35784369"> </ext-link>(<xref ref-type="bibr" rid="bib52">Zauhar et al., 2022</xref>)<break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/35784369">SRR22315424</ext-link></td><td align="left" valign="bottom">Human retina</td><td align="left" valign="bottom"><italic>CTNNBIP1</italic></td><td align="left" valign="bottom"><italic>CLSTN1</italic></td><td align="left" valign="bottom">1:9871187:-</td><td align="left" valign="bottom">1:9773394:-</td></tr></tbody></table></table-wrap></sec><sec id="s2-3"><title><italic>CTCL</italic> knockdown obstructed NR differentiation but prompted the RPE differentiation</title><p>According to the chimeric <italic>CTCL</italic> RNA expression levels (<xref ref-type="fig" rid="fig4">Figure 4A</xref>), we focused on the D60 In-frame <italic>CTCL</italic> to explore its function. A CRX-tdTomato reporter hPSC line was used in the <italic>CTCL</italic>-knockdown experiment. This cell line is derived from H9 cells and it has been shown that tdTomato follows CRX expression spatiotemporally and the cells had the same organoid yield as H9 cells, suggesting that genetic modification of H9 did not affect its developmental process (<xref ref-type="bibr" rid="bib37">Pan et al., 2020</xref>). ROs were differentiated according to the previous report (<xref ref-type="bibr" rid="bib25">Lowe et al., 2016</xref>; <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref> and <xref ref-type="video" rid="video1">Video 1</xref>). Lentiviruses carrying <italic>shCTCL</italic> (short-hairpin <italic>CTCL</italic>) or scramble <italic>shRNA</italic> (see Key resources table) infected the retinal cells at D12. After 3 days, cells were harvested for analysis of knockdown efficiency (<xref ref-type="fig" rid="fig6">Figure 6A,B</xref>). Compared with the scramble shRNA group, the In-frame <italic>CTCL</italic> RNA level was reduced to approximately 70% (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). The RNA levels of the parental genes, <italic>CTNNBIP1</italic> and <italic>CLSTN1,</italic> showed no significant differences compared to the scramble <italic>shRNA</italic> group (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2</xref>).</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>The <italic>CTCL</italic> knockdown obstructed neural retina’s (NR) cell fates but prompted the retinal pigment epithelial (RPE) differentiation.</title><p>(<bold>A</bold>) A schema illustrated the <italic>shRNA</italic> experiments. A CRX-tdTomato report line was used in this experiment. The <italic>shCTCL</italic> or scramble <italic>shRNA</italic> lentivirus transfected the retinal cells in three independent experiments on D12. All samples for <italic>shRNA</italic> experiments were collected on day 60, except those for analysis of knockdown efficiency. (<bold>B</bold>) Samples were obtained 48–72 hr after infection to examine the knockdown efficiency. There were two technical replicates for three independent experiments, <italic>t</italic>-test, ***, p &lt; 0.001. Data were shown as mean ± standard deviation (SD). Scale bar = 200 μm. (<bold>C</bold>) D60 scramble <italic>shRNA</italic>-transfected retinal organoids (ROs) displayed a typical morphology of ROs with the expression of CRX. <italic>ShCTCL</italic>-transfected organoids showed thinner outer layers with much less CRX expression. BF, bright-field images, same as below.Scale bars = 200 μm. (<bold>D</bold>) The <italic>shCTCL</italic> group displayed much thinner outer layers (orange arrows in right panel). The outer layer thickness of 25 organoids from each group was measured for statistics analysis, <italic>t</italic>-test, ****, p &lt; 0.0001. Data were shown as mean ± SD. Scale bar = 400 μm.(<bold>E</bold>) The section immunostaining of neural progenitor markers PAX6 and OTX2, and differentiated cell markers CRX, in <italic>shCTCL</italic>-treated organoids. Scale bars = 100 μm. (<bold>F</bold>) Whole-mount immunostaining of <italic>shCTCL</italic>-transfected organoids with CRX, <italic>shCTCL</italic>, and RPE-specific markers MITF and BEST1. Scale bars = 100 μm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92523-fig6-v3.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Retinal organoid (RO) differentiation at different timepoints.</title><p>This RO differentiation method was a combination of 2D and 3D culture. On D60, CTCL downregulated organoids displayed a thinner outer layer. Live imaging showed that D60 organoids expressed CRX reporter tdTomato (red) and shCTCL reporter GFP (green). Scale bars = 400 μm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92523-fig6-figsupp1-v3.tif"/></fig><fig id="fig6s2" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 2.</label><caption><title>The qRT-PCR quantification of CTCL parental gene expression.</title><p>(<bold>A</bold>) The knockdown experiments showed no effect on the RNA expression levels of CTNNBIP1, <italic>n</italic> = 4, <italic>t</italic>-test, p &gt; 0.05. (<bold>B</bold>) The knockdown experiments showed no effect on the RNA expression levels of CLSTN1, <italic>n</italic> = 4, <italic>t</italic>-test, p &gt; 0.05.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92523-fig6-figsupp2-v3.tif"/></fig><fig id="fig6s3" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 3.</label><caption><title>Cryosection immunofluorescence staining of D60 organoids.</title><p>Immunostaining of retinal pigment epithelial (RPE)-specific marker MITF on CTCL-knockdown organoids (<bold>A</bold>) and scramble shRNA organoids (<bold>B</bold>). Immunostaining of RPE-specific marker RPE65 on CTCL-knockdown organoids (<bold>C</bold>) and scramble shRNA organoids (<bold>D</bold>). The lower panel showed the amplified images of the indicated areas. Immunostaining of PAX6 on CTCL-knockdown organoids (<bold>E</bold>) and scramble shRNA organoids (<bold>F</bold>). Scale bars = 100 μm. BF, bright-field images.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92523-fig6-figsupp3-v3.tif"/></fig></fig-group><media mimetype="video" mime-subtype="mp4" xlink:href="elife-92523-video1.mp4" id="video1"><label>Video 1.</label><caption><title>The 4 days live-cell imaging of retinal organoid differentiation from D3 to D7.</title></caption></media><p>At D60, ROs with scramble <italic>shRNA</italic> displayed the typical RO morphology with the generation of photoreceptor precursors (CRX<sup>+</sup>) (<xref ref-type="fig" rid="fig6">Figure 6C</xref>, upper panel, live-cell imaging). In the <italic>shCTCL</italic> group, the organoid morphology changed with a thinner outer layer, and the CRX proteins diminished where the pigments appeared (<xref ref-type="fig" rid="fig6">Figure 6C</xref>, lower panel, live-cell imaging). The average thickness of the outer layers in those two groups was calculated (<xref ref-type="fig" rid="fig6">Figure 6D</xref>, outer layer indicated with orange arrows, live-cell imaging), and there is a dramatic decrease in the outer layer thickness in the <italic>shCTCL</italic> group.</p><p>To identify the aberrations in cell fate specification caused by <italic>CTCL</italic> knockdown, we examined the organoids with RPC-specific markers, PAX6 and OTX2. It was shown that PAX6 was highly expressed, but OTX2 was much less, and CRX appeared where GFP (<italic>shCTC</italic>L) was relatively lower (<xref ref-type="fig" rid="fig6">Figure 6E</xref>). CRX is known to be highly expressed in photoreceptors and precursors but low in mature RPE (<xref ref-type="bibr" rid="bib22">Lidgerwood et al., 2021</xref>). Since the organoids acquired the features of RPE, we hypothesized that the outer layer of <italic>CTCL</italic>-knockdown organoids switched to the RPE fate. To further confirm this, the organoids were immunostained with RPE-specific markers, MITF, BEST1, and RPE65, which were present in the nucleus, cytoplasm, and intracellular regions, respectively (<xref ref-type="fig" rid="fig6">Figure 6F</xref>, <xref ref-type="fig" rid="fig6s3">Figure 6—figure supplement 3A, C</xref>). In contrast, no pigments or RPE-specific markers were observed in the scramble <italic>shRNA</italic> group, only the PAX6 was detected in the nucleus (<xref ref-type="fig" rid="fig6s3">Figure 6—figure supplements 3B, D–F</xref>). The <italic>shCTCL</italic> green fluorescence in <xref ref-type="fig" rid="fig6">Figure 6E–F</xref> was captured with live imaging and the signal was not amplified with anti-GFP antibodies; as a result, the weaker green signals can not be seen in the images. Taken together, these results indicate that <italic>CTCL</italic> is essential for the ROs’ differentiation and that <italic>CTCL</italic> knockdown would promote the RPE cell fate at the expense of neural retinal cells.</p></sec><sec id="s2-4"><title>The underlying molecular changes in <italic>CTCL</italic>-knockdown ROs</title><p>The above results suggest that <italic>CTCL</italic> is essential for cell fate conversion in normal retinogenesis. To investigate the underlying molecular regulation, we compared the transcriptomes of <italic>shCTCL-</italic> and scramble <italic>shRNA</italic>-treated organoids by bulk RNA-seq. We obtained 3901 differentially expressed genes (DEGs) (<italic>shCTCL</italic> vs. scramble <italic>shRNA</italic>, |Log<sub>2</sub>(fold change)| &gt; 1, p-value &lt;0.05), among which 2720 were upregulated and 1181 downregulated (<xref ref-type="fig" rid="fig7">Figure 7A,B</xref>).</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Transcriptomic alterations in <italic>CTCL</italic>-knockdown retinal organoids.</title><p>(<bold>A</bold>) Volcano plot shows differentially expressed genes (DEGs, p-values &lt;0.05 and |Log<sub>2</sub>(<italic>shCTCL</italic>/scramble)| &gt; 1) between <italic>shCTCL-</italic> and scramble <italic>shRNA</italic>-treated organoids at D60. (<bold>B</bold>) Heatmap of DEGs in <italic>shCTCL-</italic> and scramble <italic>shRNA</italic>-treated organoids. (<bold>C</bold>) Functional enrichment analysis of up- and downregulated DEGs. (<bold>D</bold>) Gene Set Enrichment Analysis (GSEA) results showed the enriched gene sets in <italic>shCTCL</italic>-treated organoids using the c8 reference gene set. (<bold>E</bold>) Expression of retinal pigment epithelial (RPE)-related genes in <italic>shCTCL</italic>- and scramble <italic>shRNA</italic>-treated organoids. (<bold>F</bold>) GSEA results showed the enriched gene sets in <italic>shCTCL</italic>-treated organoids using the hallmark reference gene set. (<bold>G</bold>) Expression of epithelial–mesenchymal transition (EMT)-related genes in <italic>shCTC</italic>L- and scramble <italic>shRNA</italic>-treated organoids.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92523-fig7-v3.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>Expression of CTCL is lower in differentiated retinal pigment epithelial (RPE) cells.</title><p>(<bold>A</bold>) Bright-filed image of mature RPE differentiated from iPSCs. (<bold>B</bold>) The RT-qPCR results of CTCL RNA expression levels in D60 CTCL-knockdown organoids and the differentiated RPEs at the indicated timepoints. It showed that CTCL was expressed at a lower level in RPEs, even compared with that in the shCTCL-treated retinal organoids, <italic>n</italic> = 4, <italic>t</italic>-test, ****, p &lt; 0.0001.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92523-fig7-figsupp1-v3.tif"/></fig><fig id="fig7s2" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 2.</label><caption><title>Validation of epithelial–mesenchymal transition (EMT)-related genes by PCR.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92523-fig7-figsupp2-v3.tif"/></fig></fig-group><p>To investigate the biological pathways affected by the loss-of-function of <italic>CTCL</italic>, we performed functional enrichment for up- and downregulated DEGs using Metascape. Upregulated DEGs were significantly enriched in pathways associated with extracellular matrix organization, morphogenesis, and epithelial cell differentiation. On the other hand, downregulated DEGs were significantly enriched in the neurogenesis-associated pathways (<xref ref-type="fig" rid="fig7">Figure 7C</xref>). To further understand the changes in cell composition between <italic>shCTCL-</italic> and scramble <italic>shRNA</italic>-treated organoids, we used the Gene Set Enrichment Analysis (GSEA) to analyze the whole-gene expression lists of the organoids. GSEA analysis with c8 as the reference gene set (<xref ref-type="bibr" rid="bib32">Mootha et al., 2003</xref>; <xref ref-type="bibr" rid="bib43">Subramanian et al., 2005</xref>) revealed that genes of RPE, ocular corneal, and conjunctival epithelial cells were significantly upregulated in <italic>shCTCL</italic> organoids; however, all genes related to neural retinal component cells (photoreceptor cells, Müller glial cells, horizontal cell, amacrine cell, and retinal ganglion cell) were downregulated (<xref ref-type="fig" rid="fig7">Figure 7D</xref>). Moreover, the expression pattern of RPE-related genes in <italic>shCTCL</italic> organoids was closer to that of RPE from induced pluripotent stem cells (<xref ref-type="bibr" rid="bib28">Maruotti et al., 2015</xref>; <xref ref-type="fig" rid="fig7">Figure 7E</xref> and <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1A</xref>). At the same time, <italic>CTCL</italic> remains in a low expression state during RPE development (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1B</xref>). These results suggest that <italic>CTCL</italic> has a positive role in the normal development of ROs and that <italic>CTCL</italic> deficiency would promote the differentiation of RPCs toward RPE.</p><p>To further explore the molecular mechanisms involved in this process, we performed the GSEA analysis using hallmark gene sets (<xref ref-type="bibr" rid="bib32">Mootha et al., 2003</xref>; <xref ref-type="bibr" rid="bib43">Subramanian et al., 2005</xref>). The most significantly enriched pathway was epithelial–mesenchymal transition (EMT) (<xref ref-type="fig" rid="fig7">Figure 7F</xref>). And most of the EMT-related genes were relatively highly expressed in <italic>shCTCL</italic>-treated organoids (<xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2</xref>) (<xref ref-type="fig" rid="fig7">Figure 7G</xref>), which is particularly essential for neural crest delamination in vertebrates and the generation of different tissues during development (<xref ref-type="bibr" rid="bib13">Kim et al., 2014b</xref>). Therefore, the downregulation of <italic>CTCL</italic> expression activated the EMT pathway which altered the directions of cell differentiation.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>The term ‘chimeric RNA’ refers to any transcript composed of transcripts from different parental genes, including gene fusion transcripts (<xref ref-type="bibr" rid="bib48">Wu et al., 2019</xref>). Chimeric RNAs with two parental gene sequences will further generate new dysregulated wild-type proteins, new fusion proteins, and new non-coding RNAs, expanding the abundance of the transcriptome and proteome. The first chimeric RNA that lacks DNA alterations is <italic>AML1-ETO</italic>, which is associated with acute myeloid leukemia (<xref ref-type="bibr" rid="bib18">Langabeer et al., 1997</xref>). Subsequently, cis-splicing between neighboring genes was also found to generate chimeric RNAs, such as the CTCF-sensitive cis-spliced fusion RNAs <italic>ADCK4-NUMBL</italic> in prostate cancer (<xref ref-type="bibr" rid="bib39">Qin et al., 2015</xref>). In addition, chimeric RNAs can be generated by long-range inter- and intra-chromosomal trans-splicing (<xref ref-type="bibr" rid="bib19">Li et al., 2008</xref>). Early phase of studies has focused on the role of chimeric RNAs in cancer, where they contribute to cancer development, and serve as biomarkers and therapeutic targets.</p><p>Advances in sequencing technology have facilitated the identification of chimeric RNAs and have stimulated the research in the field of cancer. However, researchers have also found that there are some misunderstandings about chimeric RNAs. For example, <italic>PAX3-FOXO1</italic> was initially identified as a biomarker for alveolar rhabdomyosarcoma (<xref ref-type="bibr" rid="bib42">Singh et al., 2022</xref>), but was later found to be present during normal muscle differentiation. <italic>PAX3-FOXO1</italic> is transiently required for muscle lineage commitment (<xref ref-type="bibr" rid="bib49">Xie et al., 2019</xref>), and can escape miR-495 regulation during muscle differentiation. If <italic>PAX3-FOXO1</italic> is not withdrawn at the right timing, it can lead to tumorigenesis. <italic>DUS4L-BCAP29</italic> was originally identified in gastric cancer, where it promotes cell proliferation and is therefore considered to have tumorigenic potential (<xref ref-type="bibr" rid="bib12">Kim et al., 2014a</xref>). <italic>DUS4L-BCAP29</italic> was subsequently identified in human non-cancerous tissues (<xref ref-type="bibr" rid="bib45">Tang et al., 2017</xref>), and its role in promoting cell proliferation is not unique to cancer cells. It is a chimeric RNA present in normal physiology with a function in promoting neural differentiation (<xref ref-type="bibr" rid="bib46">Tang et al., 2019</xref>). Therefore, studying chimeric RNAs in normal tissues has two implications: first, we can learn more about the normal physiological functions of chimeric RNAs; second, we can establish a control baseline for the discovery of tumor markers.</p><p>It is now well established that chimeric RNAs are abundant in normal human tissues and play a regulatory role in cellular activities. In this work, we investigated chimeric RNAs in retina for the first time. We present the expression atlas of chimeric RNAs throughout the developing ROs mimicking human retinas at various development stages. As a recently identified chimeric RNA, and the In-frame <italic>CTCL</italic> was reported to play a key role in cerebral development (<xref ref-type="bibr" rid="bib36">Ou et al., 2021</xref>). Using the ROs as a model for loss-of-function experiments, we found that the In-frame <italic>CTCL</italic> also has a key role in the development of the retina and that <italic>CTCL</italic> deficiency inhibited NR differentiation but induced the RPE differentiation.</p><p>In-frame <italic>CTCL</italic> is generated by cis-splicing fusion of the first 5 exons of <italic>CTNNBIP1</italic> and the last 17 exons of <italic>CLSTN1</italic>. The 5′ parental gene <italic>CTNNBIP1</italic> encodes a receptor for β-catenin, and their binding promotes the catabolism of β-catenin, which in turn puts the Wnt pathway in an inactive state (<xref ref-type="bibr" rid="bib7">Fu et al., 2018</xref>). Its mutation has been shown to be associated with anterior segment dysgenesis 5 in the human disease database MalaCards (<ext-link ext-link-type="uri" xlink:href="https://www.malacards.org/">https://www.malacards.org/</ext-link>). <italic>CLSTN1</italic> is a member of the calsyntenin family, a subset of the cadherin superfamily. It can mediate the axonal anterograde transport of certain types of vesicles (<xref ref-type="bibr" rid="bib33">Nagase et al., 1998</xref>). The interesting question is that whether <italic>CTCL</italic> retains the biparental functions and/or acquires novel functions? Previous report demonstrated that <italic>CTCL</italic> could fine-tune Wnt signaling to regulate cerebral development (<xref ref-type="bibr" rid="bib36">Ou et al., 2021</xref>). Therefore, in this study, we had expected <italic>CTCL</italic> to function by modulating the Wnt signaling pathway or by impacting vesicular trafficking. However, surprisingly, the GSEA and DEG functional enrichment results did not show significant changes in these two biological pathways (<xref ref-type="fig" rid="fig6">Figure 6C, D, F</xref>). The differences between the <italic>shCTCL-</italic> or scramble <italic>shRNA</italic>-treated organoids were mainly in EMT, extracellular matrix organization, morphogenesis, epithelial cell differentiation, and neurogenesis-associated pathways, suggesting that even the same chimeric RNAs may function differently in close tissues.</p><p>In summary, we have identified the chimeric RNAs in the developing human ROs and found that loss-of-function of <italic>CTCL</italic> inhibited NR differentiation while prompted the RPE differentiation. Although this chimeric RNA has been previously reported in the cerebral cortex and the retina is also part of the CNS, the two tissues differ in morphology, cellular composition, development, and function. Moreover, we have made new discoveries regarding the function and mechanism of <italic>CTCL</italic>. This study revealed for the first time a key role of chimeric RNAs in human retinal development, providing new insights into the role of chimeric RNAs in regulating tissue development. In the future, we will investigate more unreported chimeric RNAs in retinal development to further illustrate the critical role of chimeric RNAs in human retinal development.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Cell line (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">CRX-tdTomato human ES reporter line-H9</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/32831148/">32831148</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Available upon reasonable request.</td></tr><tr><td align="left" valign="bottom">Cell line (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">iPSCs1</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/32831139/">36714839</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Available upon reasonable request.</td></tr><tr><td align="left" valign="bottom">Cell line (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">iPSCs2</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/35451725/">35451725</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Available upon reasonable request.</td></tr><tr><td align="left" valign="bottom">Cell line (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">iPSCs3</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33970142/">33970142</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Available upon reasonable request.</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resources/data/record/nif-0000-07730-1/AB_2801238/resolver?q=anti-PAX6%20Biolegend&amp;l=anti-PAX6%20Biolegend&amp;i=rrid:ab_2801238-2736694">anti-Pax6</ext-link><break/>(rabbit polyclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat.# 862002<break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_3076431">AB_3076431</ext-link></td><td align="left" valign="bottom">Dilution: 1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-Ki67 (rabbit polyclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Cat.# ab15580 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_443209">AB_443209</ext-link></td><td align="left" valign="bottom">Dilution: 1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-OTX2 （rabbit monoclonal）</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Cat.# ab183951<break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_3076432">AB_3076432</ext-link></td><td align="left" valign="bottom">Dilution: 1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-HuC/D （mouse monoclonal）</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">Cat.# A21271<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_221448">AB_221448</ext-link></td><td align="left" valign="bottom">Dilution: 1:100</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-SOX2 （mouse monoclonal）</td><td align="left" valign="bottom">Santa Cruz</td><td align="left" valign="bottom">Cat.# sc-365823<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10842165">AB_10842165</ext-link></td><td align="left" valign="bottom">Dilution: 1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-MITF （mouse monoclonal）</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Cat.# ab3201<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_303601">AB_303601</ext-link></td><td align="left" valign="bottom">Dilution: 1:100</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-GFAP (mouse monoclonal)</td><td align="left" valign="bottom">Santa Cruz</td><td align="left" valign="bottom">Cat.# sc-33673<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_627673">AB_627673</ext-link></td><td align="left" valign="bottom">Dilution: 1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-Sox9 (rabbit mono/oligo-colonal )</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">Cat.# 711048<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2633109">AB_2633109</ext-link></td><td align="left" valign="bottom">Dilution: 1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti- RxRγ (mouse monoclonal)</td><td align="left" valign="bottom">Santa Cruz</td><td align="left" valign="bottom">Cat.# sc-365252<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10850062">AB_10850062</ext-link></td><td align="left" valign="bottom">Dilution: 1:100</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pLenti-U6-shRNA-EF1a-EGFP-T2A-Puro-WPRE</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Available upon reasonable request.</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">UTR_CDS(truncated)-1 CTCL-forward</td><td align="left" valign="bottom">Tsingke Biotechnology Co., Ltd</td><td align="left" valign="bottom"/><td align="left" valign="bottom">TGCAAAGCCCTTGGAACA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">UTR_CDS(truncated)-1 CTCL-reverse</td><td align="left" valign="bottom">Tsingke Biotechnology Co., Ltd</td><td align="left" valign="bottom"/><td align="left" valign="bottom">TCCACTACCACTGCATCAAAG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">in-frame CTCL-forward</td><td align="left" valign="bottom">Tsingke Biotechnology Co., Ltd</td><td align="left" valign="bottom"/><td align="left" valign="bottom">TTCCTACTTCTGCCCAGCC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">in-frame CTCL-reverse</td><td align="left" valign="bottom">Tsingke Biotechnology Co., Ltd</td><td align="left" valign="bottom"/><td align="left" valign="bottom">AGGCCTGGATGGTGAATGAAT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">CDS(truncated)_intronic CTCL-forward</td><td align="left" valign="bottom">Tsingke Biotechnology Co., Ltd</td><td align="left" valign="bottom"/><td align="left" valign="bottom">GAAGAGTCCGGAGGAGATGTA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">CDS(truncated)_intronic CTCL-reverse</td><td align="left" valign="bottom">Tsingke Biotechnology Co., Ltd</td><td align="left" valign="bottom"/><td align="left" valign="bottom">ATTCTCTGCCAAGACTTACACC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">UTR_CDS(truncated)-2 CTCL-forward</td><td align="left" valign="bottom">Tsingke Biotechnology Co., Ltd</td><td align="left" valign="bottom"/><td align="left" valign="bottom">CTCCTGCTGCTGCTACTG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">UTR_CDS(truncated)-2 CTCL-reverse</td><td align="left" valign="bottom">Tsingke Biotechnology Co., Ltd</td><td align="left" valign="bottom"/><td align="left" valign="bottom">GGTCCCTTCCCACAATCATAG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">GAPDH forward</td><td align="left" valign="bottom">Tsingke Biotechnology Co., Ltd</td><td align="left" valign="bottom"/><td align="left" valign="bottom">CTCTGACTTCAACAGCGACA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">GAPDH reverse</td><td align="left" valign="bottom">Tsingke Biotechnology Co., Ltd</td><td align="left" valign="bottom"/><td align="left" valign="bottom">GTAGCCAAATTCGTTGTCATACC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">ShCTCL</td><td align="left" valign="bottom">Tsingke Biotechnology Co., Ltd</td><td align="left" valign="bottom"/><td align="left" valign="bottom">TGCTTGTTAACCTGGTCGA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Scramble</td><td align="left" valign="bottom">Tsingke Biotechnology Co, Ltd</td><td align="left" valign="bottom"/><td align="left" valign="bottom">GCCTAAGGTTAAGTCGCCCTCG</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">R (v4.0.3)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib40">R Development Core Team, 2020</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_001905">SCR_001905</ext-link></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.r-project.org/">https://www.r-project.org/</ext-link></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">FusionCatcher</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib35">Nicorici, 2023</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://github.com/ndaniel/fusioncatcher">https://github.com/ndaniel/fusioncatcher</ext-link></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Hisat2</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib15">Kim and Park, 2022</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://github.com/DaehwanKimLab/hisat2">https://github.com/DaehwanKimLab/hisat2</ext-link></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">samtools</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib4">Danecek et al., 2023</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://github.com/samtools/samtools">https://github.com/samtools/samtools</ext-link></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">featureCounts</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib21">Liao et al., 2021</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="http://subread.sourceforge.net/featureCounts.html">http://subread.sourceforge.net/featureCounts.html</ext-link></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">ggplot2</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib38">Pedersen, 2022</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://rdocumentation.org/packages/ggplot2/versions/3.3.6">https://rdocumentation.org/packages/ggplot2/versions/3.3.6</ext-link></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">ggseqlogo</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib47">Wagih, 2017</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://github.com/omarwagih/ggseqlogo">https://github.com/omarwagih/ggseqlogo</ext-link></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">chimeraviz</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib17">Lågstad, 2023</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.bioconductor.org/packages/release/bioc/html/chimeraviz.html">https://www.bioconductor.org/packages/release/bioc/html/chimeraviz.html</ext-link></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">pheatmap</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib16">Kolde, 2019</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://rdocumentation.org/search?q=pheatmap">https://rdocumentation.org/search?q=pheatmap</ext-link></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">clusterProfiler</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib51">Yu, 2012</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://rdocumentation.org/search?q=clusterProfiler">https://rdocumentation.org/search?q=clusterProfiler</ext-link></td></tr></tbody></table></table-wrap><sec id="s4-1"><title>RNA sequencing and data analysis</title><p>A total amount of 1–3 μg RNA per sample was used as input material for the RNA sample preparations. Sequencing libraries were generated using VAHTS Universal V6 RNA-seq Library Prep Kit for Illumina (NR604-01/02) following the manufacturer’s recommendations and index codes were added to attribute sequences to each sample. Briefly, mRNA was purified from total RNA using poly-T oligo-attached magnetic beads. Then we added fragmentation buffer to break the mRNA into short fragments. First-strand cDNA was synthesized using random hexamer primer and RNase H. Second-strand cDNA synthesis was subsequently performed using buffer, dNTPs, DNA polymerase I, and RNase H. And then, the double stranded cDNA was purified by AMPure P beads or QiaQuick PCR kit. The purified double-stranded cDNA was repaired at the end, added a tail and connected to the sequencing connector, then the fragment size was selected, and finally the final cDNA library was obtained by PCR enrichment.</p><p>We used FusionCatcher (<xref ref-type="bibr" rid="bib34">Nicorici et al., 2014</xref>) software (<ext-link ext-link-type="uri" xlink:href="https://github.com/ndaniel/fusioncatcher">https://github.com/ndaniel/fusioncatcher</ext-link>) to identify chimeric RNAs in human ROs. Positive chimeric RNAs identified using FusionCatcher were selected with alignment of spanning unique reads. The expression level of chimeric RNAs was reflected from log(Spanning_unique_reads/Total_number_of_reads*10,000,000) value. To analyze the expression of parental genes in human ROs, raw reads were first mapped to the hg38 human genome reference sequence by Hisat2 software, then transcripts were assembled with featureCounts. Metascape (<ext-link ext-link-type="uri" xlink:href="https://metascape.org/gp/index.html">https://metascape.org/gp/index.html</ext-link>) is used for functional annotation. The position weight matrix of the 20 bp DNA sequence motif around the fusion site was calculated by the seqLogo R package. GSEA analysis is done with the R package clusterProfiler.</p></sec><sec id="s4-2"><title>Generation of ROs from hESCs</title><p>The CRX-tdTomato human ES reporter line and iPSCs were used for the ROs differentiation. The hESCs were cultured to 80% confluence. Cell colonies were dissociated using dispase buffer (Stem cell, 07923) for 5 min at 37°C and were then cut into smaller pieces/aggregates. The aggregates were collected and mixed with Matrigel (RD). The solidified gel with ES cells were dispersed into small pieces with medium containing 1:1 mixture of Dulbecco’s modified Eagle medium (DMEM)/F12, neurobasal medium, and 0.5× N2 supplement (Gibco), 0.5× B27 supplement (Gibco), 1× MEM Non-Essential Amino Acids Solution (Gibco), 2 mM Glutamax (Gibco), and 0.1 mM 2-mercaptoenthanol. At day 1 (D1), hollow cysts could be observed in the dish and cysts started to attach to the culture dish and spread in 3 days. At D5, the cysts were dispersed into two culture dishes with same medium. Medium was changed every 5 days. On D15, detaching the cells with dispase and change to medium with DMEM/F12 (3:1), 1× B27 supplement (Gibco), and 1× MEM-NEAA (Gibco) for a week. Optic vesicles formed in this period. Finally, optic vesicles were transfered to serum medium with DMEM/F12 (3:1), 1× B27 supplement (Gibco), 1× MEM-NEAA (Gibco), 8% fetal bovine serum (Gibco), 100 mM Taurine (Sigma-Aldrich), and 2 mM Glutamax (Gibco). ROs would be collected at D60.</p></sec><sec id="s4-3"><title><italic>CTCL</italic> knockdown in the ROs</title><p>RNA interference oligo (5′-<named-content content-type="sequence">TGCTTGTTAACCTGGTCGA</named-content>-3′) against <italic>CTCL</italic> was cloned into lentivirus vector (pLenti-U6-shRNA-EF1a-EGFP-T2A-Puro-WPRE). D12 retinal cells were infected with lentiviruses ( Multiplicity of infection [MOI] = 10, the ratio of the number of transducing lentiviral particles to the number of cells) for 6 hr, and replaced with fresh medium. The fluorescence was detected after 48 hr. The expression of <italic>CTCL</italic>, <italic>CTNNBIP1</italic>, and <italic>CLSTN1</italic> in retinal cells was analyzed at D15 by quantitative PCR.</p></sec><sec id="s4-4"><title>Immunostaining of cryosections</title><p>ROs were fixed in 4% paraformaldehyde for 30 min and imbedded in O.C.T. compound and sectioned into 10 μm slices. The cryosections were blocked with 0.5% Triton X-100 in 4% bovine serum albumin (BSA) for 1 hr. After that, sections were incubated in primary antibodies (diluted in 4% BSA supplied with 0.5% Triton X-100) at 4°C overnight. The following primary antibodies were used: anti-OTX2 (1:200, Cat.# ab183951; Abcam), anti-PAX6 (1:200, Cat.# 901301; Biolegend), anti-SOX2 (1:200, Cat.# sc-365823; Santa Cruz), anti-HuC/D (1:100, Cat.# A21271; Invitrogen), anti-MITF (1:100, Cat.# ab3201; Abcam), anti-GFAP (1:200, Cat.# sc-33673; Santa Cruz), anti-Sox9 (1:200, Cat.# 711048; Invitrogen), anti-RxRγ (1:100, Cat.# sc-365252; Santa Cruz), and anti-Ki67 (1:200, Cat.# ab15580; Abcam). After washed with phosphate-buffered saline, cryosections were stained with Alexa Fluor-conjugated secondary antibodies (diluted 1:500, Invitrogen) for 1 hr at room temperature in the dark.</p></sec><sec id="s4-5"><title>Quantification and statistical analysis</title><p>Heatmap was plotted with the R package Pheatmap. All plots were drawn with R package ggplot2. Detailed statistical analysis of experiments can be found in the figure legends, including the statistical tests used, exact values, and biological replicates.</p></sec><sec id="s4-6"><title>Resource availability</title><p>Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact, Professor Zi-Bing Jin (<ext-link ext-link-type="uri" xlink:href="http://www.jin-lab.cn/english/index.html">jinzb502@ccmu.edu.cn</ext-link>).</p></sec><sec id="s4-7"><title>Materials availability</title><p>All unique/stable reagents generated in this study are available from the lead contact with a completed materials transfer agreement.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Software, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing - original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Formal analysis, Validation, Investigation, Visualization, Methodology</p></fn><fn fn-type="con" id="con3"><p>Investigation</p></fn><fn fn-type="con" id="con4"><p>Investigation</p></fn><fn fn-type="con" id="con5"><p>Writing – review and editing</p></fn><fn fn-type="con" id="con6"><p>Conceptualization, Resources, Supervision, Funding acquisition, Project administration, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>One human donor retinal sample was included in this study. The study was approved by the Ethics Committee of Beijing Tongren Hospital (No. TRECKY2021-089) and conducted in accordance with the Declaration of Helsinki.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-92523-mdarchecklist1-v3.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>Sequencing data has been deposited in GSA under accession code HRA005688 and may be accessed by application to a data access committee. The Gene Expression Omnibus (GEO) number for the bulk RNA-seq of organoids in this paper is GSE136929. All data generated or analyzed during this study is included in the manuscript and supporting files. Source data files have been provided for Figures 4C and 5A,B.</p><p>The following dataset was generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>XB</given-names></name></person-group><year iso-8601-date="2024">2024</year><data-title>CTCL in RO</data-title><source>National Genomics Data Center</source><pub-id pub-id-type="accession" xlink:href="https://ngdc.cncb.ac.cn/gsa-human/browse/HRA005688">HRA005688</pub-id></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation publication-type="data" specific-use="references" id="dataset2"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Hua</surname><given-names>Z</given-names></name><name><surname>Han</surname><given-names>F</given-names></name><name><surname>Jin</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Wu</surname><given-names>K</given-names></name><name><surname>Lv</surname><given-names>J</given-names></name><name><surname>Yu</surname><given-names>F</given-names></name><name><surname>Lin</surname><given-names>Q</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Su</surname><given-names>J</given-names></name><name><surname>Jin</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>Human embryonic stem cell-derived organoidal retinoblastoma reveals cancerous origin and therapeutic target</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE136929">GSE136929</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset3"><person-group person-group-type="author"><name><surname>Stambolian</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>Human AMD</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE155154">GSE155154</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>This study was partially supported by grants from National Natural Science Foundation of China (82125007).</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>YM</given-names></name><name><surname>Ma</surname><given-names>C</given-names></name><name><surname>Jin</surname><given-names>K</given-names></name><name><surname>Jin</surname><given-names>ZB</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Retinal organoid and gene editing for basic and translational research</article-title><source>Vision Research</source><volume>210</volume><elocation-id>108273</elocation-id><pub-id pub-id-type="doi">10.1016/j.visres.2023.108273</pub-id><pub-id pub-id-type="pmid">37307693</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clevers</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Modeling development and disease with organoids</article-title><source>Cell</source><volume>165</volume><fpage>1586</fpage><lpage>1597</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.05.082</pub-id><pub-id pub-id-type="pmid">27315476</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cowan</surname><given-names>CS</given-names></name><name><surname>Renner</surname><given-names>M</given-names></name><name><surname>De Gennaro</surname><given-names>M</given-names></name><name><surname>Gross-Scherf</surname><given-names>B</given-names></name><name><surname>Goldblum</surname><given-names>D</given-names></name><name><surname>Hou</surname><given-names>Y</given-names></name><name><surname>Munz</surname><given-names>M</given-names></name><name><surname>Rodrigues</surname><given-names>TM</given-names></name><name><surname>Krol</surname><given-names>J</given-names></name><name><surname>Szikra</surname><given-names>T</given-names></name><name><surname>Cuttat</surname><given-names>R</given-names></name><name><surname>Waldt</surname><given-names>A</given-names></name><name><surname>Papasaikas</surname><given-names>P</given-names></name><name><surname>Diggelmann</surname><given-names>R</given-names></name><name><surname>Patino-Alvarez</surname><given-names>CP</given-names></name><name><surname>Galliker</surname><given-names>P</given-names></name><name><surname>Spirig</surname><given-names>SE</given-names></name><name><surname>Pavlinic</surname><given-names>D</given-names></name><name><surname>Gerber-Hollbach</surname><given-names>N</given-names></name><name><surname>Schuierer</surname><given-names>S</given-names></name><name><surname>Srdanovic</surname><given-names>A</given-names></name><name><surname>Balogh</surname><given-names>M</given-names></name><name><surname>Panero</surname><given-names>R</given-names></name><name><surname>Kusnyerik</surname><given-names>A</given-names></name><name><surname>Szabo</surname><given-names>A</given-names></name><name><surname>Stadler</surname><given-names>MB</given-names></name><name><surname>Orgül</surname><given-names>S</given-names></name><name><surname>Picelli</surname><given-names>S</given-names></name><name><surname>Hasler</surname><given-names>PW</given-names></name><name><surname>Hierlemann</surname><given-names>A</given-names></name><name><surname>Scholl</surname><given-names>HPN</given-names></name><name><surname>Roma</surname><given-names>G</given-names></name><name><surname>Nigsch</surname><given-names>F</given-names></name><name><surname>Roska</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Cell types of the human retina and its organoids at single-cell resolution</article-title><source>Cell</source><volume>182</volume><fpage>1623</fpage><lpage>1640</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2020.08.013</pub-id><pub-id pub-id-type="pmid">32946783</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Danecek</surname><given-names>P</given-names></name><name><surname>Bonfield</surname><given-names>JK</given-names></name><name><surname>Liddle</surname><given-names>J</given-names></name><name><surname>Marshall</surname><given-names>J</given-names></name><name><surname>Ohan</surname><given-names>V</given-names></name><name><surname>Pollard</surname><given-names>MO</given-names></name><name><surname>Whitwham</surname><given-names>A</given-names></name><name><surname>Keane</surname><given-names>T</given-names></name><name><surname>McCarthy</surname><given-names>SA</given-names></name><name><surname>Davies</surname><given-names>RM</given-names></name><name><surname>Li</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2023">2023</year><data-title>Samtools</data-title><source>GitHub</source><ext-link ext-link-type="uri" xlink:href="https://github.com/samtools/samtools">https://github.com/samtools/samtools</ext-link></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>WL</given-names></name><name><surname>Gao</surname><given-names>ML</given-names></name><name><surname>Lei</surname><given-names>XL</given-names></name><name><surname>Lv</surname><given-names>JN</given-names></name><name><surname>Zhao</surname><given-names>H</given-names></name><name><surname>He</surname><given-names>KW</given-names></name><name><surname>Xia</surname><given-names>XX</given-names></name><name><surname>Li</surname><given-names>LY</given-names></name><name><surname>Chen</surname><given-names>YC</given-names></name><name><surname>Li</surname><given-names>YP</given-names></name><name><surname>Pan</surname><given-names>D</given-names></name><name><surname>Xue</surname><given-names>T</given-names></name><name><surname>Jin</surname><given-names>ZB</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Gene correction reverses ciliopathy and photoreceptor loss in IPSC-derived retinal organoids from retinitis pigmentosa patients</article-title><source>Stem Cell Reports</source><volume>10</volume><elocation-id>012</elocation-id><pub-id pub-id-type="doi">10.1016/j.stemcr.2018.05.012</pub-id><pub-id pub-id-type="pmid">29874627</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elfman</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Chimeric rna in cancer and stem cell differentiation</article-title><source>Stem Cells International</source><volume>2018</volume><elocation-id>3178789</elocation-id><pub-id pub-id-type="doi">10.1155/2018/3178789</pub-id><pub-id pub-id-type="pmid">30510584</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>X</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Qin</surname><given-names>F</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name><name><surname>Ding</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Shang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Gao</surname><given-names>Q</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Linc00210 drives Wnt/β-catenin signaling activation and liver tumor progression through CTNNBIP1-dependent manner</article-title><source>Molecular Cancer</source><volume>17</volume><elocation-id>73</elocation-id><pub-id pub-id-type="doi">10.1186/s12943-018-0783-3</pub-id><pub-id pub-id-type="pmid">29540185</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoon</surname><given-names>M</given-names></name><name><surname>Okawa</surname><given-names>H</given-names></name><name><surname>Della Santina</surname><given-names>L</given-names></name><name><surname>Wong</surname><given-names>ROL</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Functional architecture of the retina: development and disease</article-title><source>Progress in Retinal and Eye Research</source><volume>42</volume><fpage>44</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1016/j.preteyeres.2014.06.003</pub-id><pub-id pub-id-type="pmid">24984227</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Tang</surname><given-names>M</given-names></name><name><surname>Barthel</surname><given-names>F</given-names></name><name><surname>Amin</surname><given-names>S</given-names></name><name><surname>Yoshihara</surname><given-names>K</given-names></name><name><surname>Lang</surname><given-names>FM</given-names></name><name><surname>Martinez-Ledesma</surname><given-names>E</given-names></name><name><surname>Lee</surname><given-names>SH</given-names></name><name><surname>Zheng</surname><given-names>S</given-names></name><name><surname>Verhaak</surname><given-names>RGW</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>TumorFusions: an integrative resource for cancer-associated transcript fusions</article-title><source>Nucleic Acids Research</source><volume>46</volume><fpage>D1144</fpage><lpage>D1149</lpage><pub-id pub-id-type="doi">10.1093/nar/gkx1018</pub-id><pub-id pub-id-type="pmid">29099951</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>R</given-names></name><name><surname>Ye</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Tian</surname><given-names>H</given-names></name><name><surname>Du</surname><given-names>M</given-names></name><name><surname>Qu</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>M</given-names></name><name><surname>Wu</surname><given-names>B</given-names></name><name><surname>Chen</surname><given-names>R</given-names></name><name><surname>Huang</surname><given-names>G</given-names></name><name><surname>Zhong</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Yu</surname><given-names>M</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Deep Sc-RNA sequencing decoding the molecular dynamic architecture of the human retina</article-title><source>Science China Life Sciences</source><volume>66</volume><fpage>496</fpage><lpage>515</lpage><pub-id pub-id-type="doi">10.1007/s11427-021-2163-1</pub-id><pub-id pub-id-type="pmid">36115892</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>ZB</given-names></name><name><surname>Gao</surname><given-names>ML</given-names></name><name><surname>Deng</surname><given-names>WL</given-names></name><name><surname>Wu</surname><given-names>KC</given-names></name><name><surname>Sugita</surname><given-names>S</given-names></name><name><surname>Mandai</surname><given-names>M</given-names></name><name><surname>Takahashi</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Stemming retinal regeneration with pluripotent stem cells</article-title><source>Progress in Retinal and Eye Research</source><volume>69</volume><fpage>38</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1016/j.preteyeres.2018.11.003</pub-id><pub-id pub-id-type="pmid">30419340</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>HP</given-names></name><name><surname>Cho</surname><given-names>GA</given-names></name><name><surname>Han</surname><given-names>SW</given-names></name><name><surname>Shin</surname><given-names>JY</given-names></name><name><surname>Jeong</surname><given-names>EG</given-names></name><name><surname>Song</surname><given-names>SH</given-names></name><name><surname>Lee</surname><given-names>WC</given-names></name><name><surname>Lee</surname><given-names>KH</given-names></name><name><surname>Bang</surname><given-names>D</given-names></name><name><surname>Seo</surname><given-names>JS</given-names></name><name><surname>Kim</surname><given-names>JI</given-names></name><name><surname>Kim</surname><given-names>TY</given-names></name></person-group><year iso-8601-date="2014">2014a</year><article-title>Novel fusion transcripts in human gastric cancer revealed by transcriptome analysis</article-title><source>Oncogene</source><volume>33</volume><fpage>5434</fpage><lpage>5441</lpage><pub-id pub-id-type="doi">10.1038/onc.2013.490</pub-id><pub-id pub-id-type="pmid">24240688</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>YS</given-names></name><name><surname>Yi</surname><given-names>BR</given-names></name><name><surname>Kim</surname><given-names>NH</given-names></name><name><surname>Choi</surname><given-names>KC</given-names></name></person-group><year iso-8601-date="2014">2014b</year><article-title>Role of the epithelial-mesenchymal transition and its effects on embryonic stem cells</article-title><source>Experimental &amp; Molecular Medicine</source><volume>46</volume><elocation-id>e108</elocation-id><pub-id pub-id-type="doi">10.1038/emm.2014.44</pub-id><pub-id pub-id-type="pmid">25081188</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Lowe</surname><given-names>A</given-names></name><name><surname>Dharmat</surname><given-names>R</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Owen</surname><given-names>LA</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Shakoor</surname><given-names>A</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Morgan</surname><given-names>DJ</given-names></name><name><surname>Hejazi</surname><given-names>AA</given-names></name><name><surname>Cvekl</surname><given-names>A</given-names></name><name><surname>DeAngelis</surname><given-names>MM</given-names></name><name><surname>Zhou</surname><given-names>ZJ</given-names></name><name><surname>Chen</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Generation, transcriptome profiling, and functional validation of cone-rich human retinal organoids</article-title><source>PNAS</source><volume>116</volume><fpage>10824</fpage><lpage>10833</lpage><pub-id pub-id-type="doi">10.1073/pnas.1901572116</pub-id><pub-id pub-id-type="pmid">31072937</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>D</given-names></name><name><surname>Park</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>Hisat2</data-title><version designator="5086938">5086938</version><source>GitHub</source><ext-link ext-link-type="uri" xlink:href="https://github.com/DaehwanKimLab/hisat2">https://github.com/DaehwanKimLab/hisat2</ext-link></element-citation></ref><ref id="bib16"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Kolde</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2019">2019</year><data-title>Pheatmap</data-title><version designator="1.0.12">1.0.12</version><source>RDocumentation</source><ext-link ext-link-type="uri" xlink:href="https://rdocumentation.org/packages/pheatmap/versions/1.0.12">https://rdocumentation.org/packages/pheatmap/versions/1.0.12</ext-link></element-citation></ref><ref id="bib17"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Lågstad</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2023">2023</year><data-title>Chimeraviz</data-title><version designator="1.28.0">1.28.0</version><source>Bioconductor</source><ext-link ext-link-type="uri" xlink:href="https://www.bioconductor.org/packages/release/bioc/html/chimeraviz.html">https://www.bioconductor.org/packages/release/bioc/html/chimeraviz.html</ext-link></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langabeer</surname><given-names>SE</given-names></name><name><surname>Walker</surname><given-names>H</given-names></name><name><surname>Rogers</surname><given-names>JR</given-names></name><name><surname>Burnett</surname><given-names>AK</given-names></name><name><surname>Wheatley</surname><given-names>K</given-names></name><name><surname>Swirsky</surname><given-names>D</given-names></name><name><surname>Goldstone</surname><given-names>AH</given-names></name><name><surname>Linch</surname><given-names>DC</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Incidence of AML1/ETO fusion transcripts in patients entered into the MRC AML trials: MRC Adult Leukaemia Working Party</article-title><source>British Journal of Haematology</source><volume>99</volume><fpage>925</fpage><lpage>928</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2141.1997.4663270.x</pub-id><pub-id pub-id-type="pmid">9432044</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Mor</surname><given-names>G</given-names></name><name><surname>Sklar</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>A neoplastic gene fusion mimics trans-splicing of RNAs in normal human cells</article-title><source>Science</source><volume>321</volume><fpage>1357</fpage><lpage>1361</lpage><pub-id pub-id-type="doi">10.1126/science.1156725</pub-id><pub-id pub-id-type="pmid">18772439</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>YP</given-names></name><name><surname>Wang</surname><given-names>YT</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Shen</surname><given-names>RJ</given-names></name><name><surname>Jin</surname><given-names>K</given-names></name><name><surname>Jin</surname><given-names>LW</given-names></name><name><surname>Jin</surname><given-names>ZB</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Second hit impels oncogenesis of retinoblastoma in patient-induced pluripotent stem cell-derived retinal organoids: direct evidence for Knudson’s theory</article-title><source>PNAS Nexus</source><volume>1</volume><elocation-id>gac162</elocation-id><pub-id pub-id-type="doi">10.1093/pnasnexus/pgac162</pub-id><pub-id pub-id-type="pmid">36714839</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>Y</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name><name><surname>Shi</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>featureCounts: a Ultrafast and accurate read summarization program</data-title><source>SourceForge</source><ext-link ext-link-type="uri" xlink:href="https://subread.sourceforge.net/featureCounts.html">https://subread.sourceforge.net/featureCounts.html</ext-link></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lidgerwood</surname><given-names>GE</given-names></name><name><surname>Senabouth</surname><given-names>A</given-names></name><name><surname>Smith-Anttila</surname><given-names>CJA</given-names></name><name><surname>Gnanasambandapillai</surname><given-names>V</given-names></name><name><surname>Kaczorowski</surname><given-names>DC</given-names></name><name><surname>Amann-Zalcenstein</surname><given-names>D</given-names></name><name><surname>Fletcher</surname><given-names>EL</given-names></name><name><surname>Naik</surname><given-names>SH</given-names></name><name><surname>Hewitt</surname><given-names>AW</given-names></name><name><surname>Powell</surname><given-names>JE</given-names></name><name><surname>Pébay</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Transcriptomic profiling of human pluripotent stem cell-derived retinal pigment epithelium over time</article-title><source>Genomics, Proteomics &amp; Bioinformatics</source><volume>19</volume><fpage>223</fpage><lpage>242</lpage><pub-id pub-id-type="doi">10.1016/j.gpb.2020.08.002</pub-id><pub-id pub-id-type="pmid">33307245</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>YY</given-names></name><name><surname>Li</surname><given-names>YP</given-names></name><name><surname>Hua</surname><given-names>ZQ</given-names></name><name><surname>Zhang</surname><given-names>CJ</given-names></name><name><surname>Wu</surname><given-names>KC</given-names></name><name><surname>Yu</surname><given-names>F</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Su</surname><given-names>J</given-names></name><name><surname>Jin</surname><given-names>ZB</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Human embryonic stem cell-derived organoid retinoblastoma reveals a cancerous origin</article-title><source>PNAS</source><volume>117</volume><fpage>33628</fpage><lpage>33638</lpage><pub-id pub-id-type="doi">10.1073/pnas.2011780117</pub-id><pub-id pub-id-type="pmid">33318192</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Hua</surname><given-names>ZQ</given-names></name><name><surname>Jin</surname><given-names>ZB</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Modeling human retinoblastoma using embryonic stem cell-derived retinal organoids</article-title><source>STAR Protocols</source><volume>2</volume><elocation-id>100444</elocation-id><pub-id pub-id-type="doi">10.1016/j.xpro.2021.100444</pub-id><pub-id pub-id-type="pmid">33899024</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lowe</surname><given-names>A</given-names></name><name><surname>Harris</surname><given-names>R</given-names></name><name><surname>Bhansali</surname><given-names>P</given-names></name><name><surname>Cvekl</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Intercellular adhesion-dependent cell survival and ROCK-regulated actomyosin-driven forces mediate self-formation of a retinal organoid</article-title><source>Stem Cell Reports</source><volume>6</volume><fpage>743</fpage><lpage>756</lpage><pub-id pub-id-type="doi">10.1016/j.stemcr.2016.03.011</pub-id><pub-id pub-id-type="pmid">27132890</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Shiau</surname><given-names>F</given-names></name><name><surname>Yi</surname><given-names>W</given-names></name><name><surname>Lu</surname><given-names>S</given-names></name><name><surname>Wu</surname><given-names>Q</given-names></name><name><surname>Pearson</surname><given-names>JD</given-names></name><name><surname>Kallman</surname><given-names>A</given-names></name><name><surname>Zhong</surname><given-names>S</given-names></name><name><surname>Hoang</surname><given-names>T</given-names></name><name><surname>Zuo</surname><given-names>Z</given-names></name><name><surname>Zhao</surname><given-names>F</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Tsai</surname><given-names>N</given-names></name><name><surname>Zhuo</surname><given-names>Y</given-names></name><name><surname>He</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Stein-O’Brien</surname><given-names>GL</given-names></name><name><surname>Sherman</surname><given-names>TD</given-names></name><name><surname>Duan</surname><given-names>X</given-names></name><name><surname>Fertig</surname><given-names>EJ</given-names></name><name><surname>Goff</surname><given-names>LA</given-names></name><name><surname>Zack</surname><given-names>DJ</given-names></name><name><surname>Handa</surname><given-names>JT</given-names></name><name><surname>Xue</surname><given-names>T</given-names></name><name><surname>Bremner</surname><given-names>R</given-names></name><name><surname>Blackshaw</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Clark</surname><given-names>BS</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Single-cell analysis of human retina identifies evolutionarily conserved and species-specific mechanisms controlling development</article-title><source>Developmental Cell</source><volume>53</volume><fpage>473</fpage><lpage>491</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2020.04.009</pub-id><pub-id pub-id-type="pmid">32386599</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>C</given-names></name><name><surname>Jin</surname><given-names>K</given-names></name><name><surname>Jin</surname><given-names>ZB</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Generation of human patient iPSC-derived retinal organoids to model retinitis pigmentosa</article-title><source>Journal of Visualized Experiments</source><volume>01</volume><elocation-id>64045</elocation-id><pub-id pub-id-type="doi">10.3791/64045</pub-id><pub-id pub-id-type="pmid">35786611</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maruotti</surname><given-names>J</given-names></name><name><surname>Sripathi</surname><given-names>SR</given-names></name><name><surname>Bharti</surname><given-names>K</given-names></name><name><surname>Fuller</surname><given-names>J</given-names></name><name><surname>Wahlin</surname><given-names>KJ</given-names></name><name><surname>Ranganathan</surname><given-names>V</given-names></name><name><surname>Sluch</surname><given-names>VM</given-names></name><name><surname>Berlinicke</surname><given-names>CA</given-names></name><name><surname>Davis</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>C</given-names></name><name><surname>Zhao</surname><given-names>L</given-names></name><name><surname>Wan</surname><given-names>J</given-names></name><name><surname>Qian</surname><given-names>J</given-names></name><name><surname>Corneo</surname><given-names>B</given-names></name><name><surname>Temple</surname><given-names>S</given-names></name><name><surname>Dubey</surname><given-names>R</given-names></name><name><surname>Olenyuk</surname><given-names>BZ</given-names></name><name><surname>Bhutto</surname><given-names>I</given-names></name><name><surname>Lutty</surname><given-names>GA</given-names></name><name><surname>Zack</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Small-molecule-directed, efficient generation of retinal pigment epithelium from human pluripotent stem cells</article-title><source>PNAS</source><volume>112</volume><fpage>10950</fpage><lpage>10955</lpage><pub-id pub-id-type="doi">10.1073/pnas.1422818112</pub-id><pub-id pub-id-type="pmid">26269569</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masland</surname><given-names>RH</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The neuronal organization of the retina</article-title><source>Neuron</source><volume>76</volume><fpage>266</fpage><lpage>280</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2012.10.002</pub-id><pub-id pub-id-type="pmid">23083731</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehani</surname><given-names>B</given-names></name><name><surname>Narta</surname><given-names>K</given-names></name><name><surname>Paul</surname><given-names>D</given-names></name><name><surname>Raj</surname><given-names>A</given-names></name><name><surname>Kumar</surname><given-names>D</given-names></name><name><surname>Sharma</surname><given-names>A</given-names></name><name><surname>Kaurani</surname><given-names>L</given-names></name><name><surname>Nayak</surname><given-names>S</given-names></name><name><surname>Dash</surname><given-names>D</given-names></name><name><surname>Suri</surname><given-names>A</given-names></name><name><surname>Sarkar</surname><given-names>C</given-names></name><name><surname>Mukhopadhyay</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Fusion transcripts in normal human cortex increase with age and show distinct genomic features for single cells and tissues</article-title><source>Scientific Reports</source><volume>10</volume><elocation-id>1368</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-020-58165-6</pub-id><pub-id pub-id-type="pmid">31992760</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mertens</surname><given-names>F</given-names></name><name><surname>Johansson</surname><given-names>B</given-names></name><name><surname>Fioretos</surname><given-names>T</given-names></name><name><surname>Mitelman</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The emerging complexity of gene fusions in cancer</article-title><source>Nature Reviews Cancer</source><volume>15</volume><fpage>371</fpage><lpage>381</lpage><pub-id pub-id-type="doi">10.1038/nrc3947</pub-id><pub-id pub-id-type="pmid">25998716</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mootha</surname><given-names>VK</given-names></name><name><surname>Lindgren</surname><given-names>CM</given-names></name><name><surname>Eriksson</surname><given-names>KF</given-names></name><name><surname>Subramanian</surname><given-names>A</given-names></name><name><surname>Sihag</surname><given-names>S</given-names></name><name><surname>Lehar</surname><given-names>J</given-names></name><name><surname>Puigserver</surname><given-names>P</given-names></name><name><surname>Carlsson</surname><given-names>E</given-names></name><name><surname>Ridderstråle</surname><given-names>M</given-names></name><name><surname>Laurila</surname><given-names>E</given-names></name><name><surname>Houstis</surname><given-names>N</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name><name><surname>Patterson</surname><given-names>N</given-names></name><name><surname>Mesirov</surname><given-names>JP</given-names></name><name><surname>Golub</surname><given-names>TR</given-names></name><name><surname>Tamayo</surname><given-names>P</given-names></name><name><surname>Spiegelman</surname><given-names>B</given-names></name><name><surname>Lander</surname><given-names>ES</given-names></name><name><surname>Hirschhorn</surname><given-names>JN</given-names></name><name><surname>Altshuler</surname><given-names>D</given-names></name><name><surname>Groop</surname><given-names>LC</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes</article-title><source>Nature Genetics</source><volume>34</volume><fpage>267</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1038/ng1180</pub-id><pub-id pub-id-type="pmid">12808457</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagase</surname><given-names>T</given-names></name><name><surname>Ishikawa</surname><given-names>K</given-names></name><name><surname>Suyama</surname><given-names>M</given-names></name><name><surname>Kikuno</surname><given-names>R</given-names></name><name><surname>Hirosawa</surname><given-names>M</given-names></name><name><surname>Miyajima</surname><given-names>N</given-names></name><name><surname>Tanaka</surname><given-names>A</given-names></name><name><surname>Kotani</surname><given-names>H</given-names></name><name><surname>Nomura</surname><given-names>N</given-names></name><name><surname>Ohara</surname><given-names>O</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Prediction of the coding sequences of unidentified human genes XII: the complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro</article-title><source>DNA Research</source><volume>5</volume><fpage>355</fpage><lpage>364</lpage><pub-id pub-id-type="doi">10.1093/dnares/5.6.355</pub-id><pub-id pub-id-type="pmid">10048485</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Nicorici</surname><given-names>D</given-names></name><name><surname>Satalan</surname><given-names>M</given-names></name><name><surname>Edgren</surname><given-names>H</given-names></name><name><surname>Kangaspeska</surname><given-names>S</given-names></name><name><surname>Murumagi</surname><given-names>A</given-names></name><name><surname>Kallioniemi</surname><given-names>O</given-names></name><name><surname>Virtanen</surname><given-names>S</given-names></name><name><surname>Kilkku</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>FusionCatcher - a tool for finding somatic fusion genes in paired-end RNA-sequencing data</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/011650</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Nicorici</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2023">2023</year><data-title>Fusioncatcher</data-title><version designator="ebc46fd">ebc46fd</version><source>GitHub</source><ext-link ext-link-type="uri" xlink:href="https://github.com/ndaniel/fusioncatcher">https://github.com/ndaniel/fusioncatcher</ext-link></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ou</surname><given-names>MY</given-names></name><name><surname>Xiao</surname><given-names>Q</given-names></name><name><surname>Ju</surname><given-names>XC</given-names></name><name><surname>Zeng</surname><given-names>PM</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Sheng</surname><given-names>AL</given-names></name><name><surname>Luo</surname><given-names>ZG</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The CTNNBIP1-CLSTN1 fusion transcript regulates human neocortical development</article-title><source>Cell Reports</source><volume>35</volume><elocation-id>109290</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2021.109290</pub-id><pub-id pub-id-type="pmid">34192541</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>D</given-names></name><name><surname>Xia</surname><given-names>XX</given-names></name><name><surname>Zhou</surname><given-names>H</given-names></name><name><surname>Jin</surname><given-names>SQ</given-names></name><name><surname>Lu</surname><given-names>YY</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Gao</surname><given-names>ML</given-names></name><name><surname>Jin</surname><given-names>ZB</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>COCO enhances the efficiency of photoreceptor precursor differentiation in early human embryonic stem cell-derived retinal organoids</article-title><source>Stem Cell Research &amp; Therapy</source><volume>11</volume><elocation-id>366</elocation-id><pub-id pub-id-type="doi">10.1186/s13287-020-01883-5</pub-id><pub-id pub-id-type="pmid">32831148</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Pedersen</surname><given-names>TL</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>Ggplot2</data-title><version designator="3.3.6">3.3.6</version><source>RDocumentation</source><ext-link ext-link-type="uri" xlink:href="https://rdocumentation.org/packages/ggplot2/versions/3.3.6">https://rdocumentation.org/packages/ggplot2/versions/3.3.6</ext-link></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qin</surname><given-names>F</given-names></name><name><surname>Song</surname><given-names>Z</given-names></name><name><surname>Babiceanu</surname><given-names>M</given-names></name><name><surname>Song</surname><given-names>Y</given-names></name><name><surname>Facemire</surname><given-names>L</given-names></name><name><surname>Singh</surname><given-names>R</given-names></name><name><surname>Adli</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Discovery of CTCF-sensitive cis-spliced fusion RNAs between adjacent genes in human prostate cells</article-title><source>PLOS Genetics</source><volume>11</volume><elocation-id>e1005001</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1005001</pub-id><pub-id pub-id-type="pmid">25658338</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="software"><person-group person-group-type="author"><collab>R Development Core Team</collab></person-group><year iso-8601-date="2020">2020</year><data-title>R: A language and environment for statistical computing</data-title><version designator="4.0.3">4.0.3</version><publisher-loc>Vienna, Austria</publisher-loc><publisher-name>R Foundation for Statistical Computing</publisher-name><ext-link ext-link-type="uri" xlink:href="http://www.R-project.org">http://www.R-project.org</ext-link></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>S</given-names></name><name><surname>Qin</surname><given-names>F</given-names></name><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>Elfman</surname><given-names>J</given-names></name><name><surname>Lin</surname><given-names>E</given-names></name><name><surname>Pham</surname><given-names>LP</given-names></name><name><surname>Yang</surname><given-names>A</given-names></name><name><surname>Li</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The landscape of chimeric RNAs in non-diseased tissues and cells</article-title><source>Nucleic Acids Research</source><volume>48</volume><fpage>1764</fpage><lpage>1778</lpage><pub-id pub-id-type="doi">10.1093/nar/gkz1223</pub-id><pub-id pub-id-type="pmid">31965184</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>S</given-names></name><name><surname>Abu-Zaid</surname><given-names>A</given-names></name><name><surname>Jin</surname><given-names>H</given-names></name><name><surname>Fang</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Feng</surname><given-names>H</given-names></name><name><surname>Quarni</surname><given-names>W</given-names></name><name><surname>Shao</surname><given-names>Y</given-names></name><name><surname>Maxham</surname><given-names>L</given-names></name><name><surname>Abdolvahabi</surname><given-names>A</given-names></name><name><surname>Yun</surname><given-names>MK</given-names></name><name><surname>Vaithiyalingam</surname><given-names>S</given-names></name><name><surname>Tan</surname><given-names>H</given-names></name><name><surname>Bowling</surname><given-names>J</given-names></name><name><surname>Honnell</surname><given-names>V</given-names></name><name><surname>Young</surname><given-names>B</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Bajpai</surname><given-names>R</given-names></name><name><surname>Pruett-Miller</surname><given-names>SM</given-names></name><name><surname>Grosveld</surname><given-names>GC</given-names></name><name><surname>Hatley</surname><given-names>M</given-names></name><name><surname>Xu</surname><given-names>B</given-names></name><name><surname>Fan</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>G</given-names></name><name><surname>Chen</surname><given-names>EY</given-names></name><name><surname>Chen</surname><given-names>T</given-names></name><name><surname>Lewis</surname><given-names>PW</given-names></name><name><surname>Rankovic</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Murphy</surname><given-names>AJ</given-names></name><name><surname>Easton</surname><given-names>J</given-names></name><name><surname>Peng</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>White</surname><given-names>SW</given-names></name><name><surname>Davidoff</surname><given-names>AM</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Targeting KDM4 for treating PAX3-FOXO1-driven alveolar rhabdomyosarcoma</article-title><source>Science Translational Medicine</source><volume>14</volume><elocation-id>eabq2096</elocation-id><pub-id pub-id-type="doi">10.1126/scitranslmed.abq2096</pub-id><pub-id pub-id-type="pmid">35857643</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subramanian</surname><given-names>A</given-names></name><name><surname>Tamayo</surname><given-names>P</given-names></name><name><surname>Mootha</surname><given-names>VK</given-names></name><name><surname>Mukherjee</surname><given-names>S</given-names></name><name><surname>Ebert</surname><given-names>BL</given-names></name><name><surname>Gillette</surname><given-names>MA</given-names></name><name><surname>Paulovich</surname><given-names>A</given-names></name><name><surname>Pomeroy</surname><given-names>SL</given-names></name><name><surname>Golub</surname><given-names>TR</given-names></name><name><surname>Lander</surname><given-names>ES</given-names></name><name><surname>Mesirov</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles</article-title><source>PNAS</source><volume>102</volume><fpage>15545</fpage><lpage>15550</lpage><pub-id pub-id-type="doi">10.1073/pnas.0506580102</pub-id><pub-id pub-id-type="pmid">16199517</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>LF</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Chen</surname><given-names>XJ</given-names></name><name><surname>Wang</surname><given-names>XY</given-names></name><name><surname>Zhang</surname><given-names>BW</given-names></name><name><surname>Ji</surname><given-names>YY</given-names></name><name><surname>Wu</surname><given-names>KC</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Jin</surname><given-names>ZB</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Circular RNAs in human and vertebrate neural retinas</article-title><source>RNA Biology</source><volume>16</volume><fpage>821</fpage><lpage>829</lpage><pub-id pub-id-type="doi">10.1080/15476286.2019.1591034</pub-id><pub-id pub-id-type="pmid">30874468</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>Y</given-names></name><name><surname>Qin</surname><given-names>F</given-names></name><name><surname>Liu</surname><given-names>A</given-names></name><name><surname>Li</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Recurrent fusion RNA DUS4L-BCAP29 in non-cancer human tissues and cells</article-title><source>Oncotarget</source><volume>8</volume><fpage>31415</fpage><lpage>31423</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.16329</pub-id><pub-id pub-id-type="pmid">28415823</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>Y</given-names></name><name><surname>Ma</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Xing</surname><given-names>Q</given-names></name><name><surname>Huang</surname><given-names>T</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>Yao</surname><given-names>M</given-names></name><name><surname>Yang</surname><given-names>GL</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Zang</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>B</given-names></name><name><surname>Guan</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Identification of chimeric RNAs in human infant brains and their implications in neural differentiation</article-title><source>The International Journal of Biochemistry &amp; Cell Biology</source><volume>111</volume><fpage>19</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1016/j.biocel.2019.03.012</pub-id><pub-id pub-id-type="pmid">30959201</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wagih</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>ggseqlogo: a versatile R package for drawing sequence logos</article-title><source>Bioinformatics</source><volume>33</volume><fpage>3645</fpage><lpage>3647</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btx469</pub-id><pub-id pub-id-type="pmid">29036507</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Gene fusions and chimeric RNAs, and their implications in cancer</article-title><source>Genes &amp; Diseases</source><volume>6</volume><fpage>385</fpage><lpage>390</lpage><pub-id pub-id-type="doi">10.1016/j.gendis.2019.08.002</pub-id><pub-id pub-id-type="pmid">31832518</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>Z</given-names></name><name><surname>Tang</surname><given-names>Y</given-names></name><name><surname>Su</surname><given-names>X</given-names></name><name><surname>Cao</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>PAX3-FOXO1 escapes miR-495 regulation during muscle differentiation</article-title><source>RNA Biology</source><volume>16</volume><fpage>144</fpage><lpage>153</lpage><pub-id pub-id-type="doi">10.1080/15476286.2018.1564464</pub-id><pub-id pub-id-type="pmid">30593263</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Akhtar</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Yi</surname><given-names>W</given-names></name><name><surname>Sun</surname><given-names>X</given-names></name><name><surname>Zuo</surname><given-names>Z</given-names></name><name><surname>Wei</surname><given-names>M</given-names></name><name><surname>Fang</surname><given-names>X</given-names></name><name><surname>Yao</surname><given-names>Z</given-names></name><name><surname>Dong</surname><given-names>K</given-names></name><name><surname>Zhong</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Shen</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>H</given-names></name><name><surname>Bao</surname><given-names>J</given-names></name><name><surname>Qu</surname><given-names>K</given-names></name><name><surname>Xue</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Chromatin accessibility analysis reveals regulatory dynamics of developing human retina and hiPSC-derived retinal organoids</article-title><source>Science Advances</source><volume>6</volume><elocation-id>eaay5247</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.aay5247</pub-id><pub-id pub-id-type="pmid">32083182</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2012">2012</year><data-title>clusterProfiler</data-title><version designator="3.0.4">3.0.4</version><source>RDocumentation</source><ext-link ext-link-type="uri" xlink:href="https://rdocumentation.org/packages/clusterProfiler/versions/3.0.4">https://rdocumentation.org/packages/clusterProfiler/versions/3.0.4</ext-link></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zauhar</surname><given-names>R</given-names></name><name><surname>Biber</surname><given-names>J</given-names></name><name><surname>Jabri</surname><given-names>Y</given-names></name><name><surname>Kim</surname><given-names>M</given-names></name><name><surname>Hu</surname><given-names>J</given-names></name><name><surname>Kaplan</surname><given-names>L</given-names></name><name><surname>Pfaller</surname><given-names>AM</given-names></name><name><surname>Schäfer</surname><given-names>N</given-names></name><name><surname>Enzmann</surname><given-names>V</given-names></name><name><surname>Schlötzer-Schrehardt</surname><given-names>U</given-names></name><name><surname>Straub</surname><given-names>T</given-names></name><name><surname>Hauck</surname><given-names>SM</given-names></name><name><surname>Gamlin</surname><given-names>PD</given-names></name><name><surname>McFerrin</surname><given-names>MB</given-names></name><name><surname>Messinger</surname><given-names>J</given-names></name><name><surname>Strang</surname><given-names>CE</given-names></name><name><surname>Curcio</surname><given-names>CA</given-names></name><name><surname>Dana</surname><given-names>N</given-names></name><name><surname>Pauly</surname><given-names>D</given-names></name><name><surname>Grosche</surname><given-names>A</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Stambolian</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>As in real estate, location matters: cellular expression of complement varies between macular and peripheral regions of the retina and supporting tissues</article-title><source>Frontiers in Immunology</source><volume>13</volume><elocation-id>895519</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2022.895519</pub-id><pub-id pub-id-type="pmid">35784369</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Jin</surname><given-names>ZB</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Retinal organoids as models for development and diseases</article-title><source>Cell Regeneration</source><volume>10</volume><elocation-id>33</elocation-id><pub-id pub-id-type="doi">10.1186/s13619-021-00097-1</pub-id><pub-id pub-id-type="pmid">34719743</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.92523.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Sappington</surname><given-names>Rebecca M</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04v8djg66</institution-id><institution>Wake Forest Baptist Medical Center</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><p>The primary goal of this paper is to profile expression of chimeric RNAs in human retinal organoids throughout development. The fundamental findings provide an important step forward in understanding retinogenesis specifically and neurogenesis, generally. The compelling evidence unveils a previously unrecognized significant role of chimeric RNA CTCL in human retinal development.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.92523.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Sappington</surname><given-names>Rebecca M</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04v8djg66</institution-id><institution>Wake Forest Baptist Medical Center</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting the paper &quot;Profiling of chimeric RNAs in human retinal development with retinal organoids&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by a Senior Editor.</p><p>Comments to the Authors:</p><p>We are sorry to say that, after consultation with the reviewers, we have decided that this work will not be considered further for publication by <italic>eLife</italic>.</p><p>The consensus of the reviewers is that, while the work has strong potential for impact, concerns surrounding replication and reproducibility undermine the findings in this manuscript. Below is a detailed summary of reviewer comments:</p><p>Strengths</p><p>1. Novel study from the perspective of defining a role for chRNAs in early retinal development.</p><p>2. Criteria and characterization parameters for the chimeric dataset are well-described and thoughtful.</p><p>3. Evaluation of CTCL provides a functional valuation of the chimeric dataset and identifies a potential role in epithelial-mesenchymal transition (EMT), which is an interesting mechanism for cell fate switches in developmental and pathological processes.</p><p>Weaknesses</p><p>1. Studies appear to be limited to the use of a single cell line, which does not take into account variability between cell lines or between individuals. The field standard is 3 parent lines.</p><p>2. While the coverage of 8 developmental stages is commendable, it seems that this suggests that an average of less than 3 retinal organoids was assessed at each developmental stage. With significant variability often observed between organoids, the use of an extremely limited number of organoids like this is further concerning.</p><p>3. While the authors have published on the differentiation of retinal organoids in the past, and they discuss some features of retinal organoids at various developmental stages in this manuscript, it would strengthen the paper for the casual reader if some of this info was presented in Figure 1. For example, what is the significance of each developmental stage assessed, and how are the organoids characterized at each point? Representative immunostaining of organoids along with a description at each time point would greatly assist in the understanding of this study for those that are not up to date on retinal organoids.</p><p>4. Concerns exist about the ability to reproduce these studies based on methods provided in the manuscript. For example, while the authors state that the &quot;CRX-tdTomato human ES reporter line was used for the ROs differentiation&quot;, this does not state which cell line this actually is, nor whether this is an established cell line that has been previously characterized or not. More detail needs to be provided here and if this is a new reporter line extensive characterization needs to be performed.</p><p>5. Some representative images in Figure 5 suggest that most cells are not transduced with shRNA, and sometimes very few are transduced. This is particularly concerning for scramble controls such as those observed in Figure 5C, where it appears that perhaps just 1 or 2 cells are transduced based upon the GFP reporter. It is not clear how much this variability affects these experiments, and the figures as presented suggest that scramble controls may not be better than untransduced cultures.</p><p>6. Evidence for EMT is solely based on RNA sequencing. The authors should at least provide the qRT-PCR verifications.</p><p>7. The Discussion section should provide greater context for the findings of the study, including recent progress in the roles of chRNAs (and the mechanisms) in tissue development and maintenance, differential functions in tumors and normal tissues should have compared and distinguished in the discussion, and relevance of loss of function studies to the retina, i.e. anterior segment dysgenesis 5 is a developmental disorder of the eye associated with mutations in CTNNBIP1.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>The purpose of this study is to profile chimeric RNAs expression during human retinal development. Chimeric RNAs regulate stem/progenitor cell differentiation, stemness maintenance and central nervous system development. Using human embryonic stem cells (hESC)-derived retinal organoids (day 0 to day 120), the study profiled chimeric RNAs with RNA sequencing. This profiling identified several chimeric RNAs with commonality to neuronal differentiation and stem cell maintenance as well as chimeric RNAs that appear specific to retinogenesis. Based on these data, the functional significance of chimeric RNA CTNNBIP1-CLSTN1 (CTCL) in retinogenesis was examined. CTCL shRNA studies in human retinal organoids revealed that CTCL loss-of-function obstructs neural differentiation, but promotes of retinal pigment epithelial differentiation. These data provide an important step forward in understanding retinogenesis specifically and central nervous system development, generally.</p><p>Strengths</p><p>1. Reports first, the unbiased profile of chimeric RNA expression across a broad developmental period in human-derived retinal organoids.</p><p>2. Criteria and characterization parameters for the chimeric dataset are well-described and thoughtful.</p><p>3. Functional follow-up on CTCL identifies a novel role for this chimeric RNA in human retinogenesis and demonstrates the utility of the chimeric RNA profile more broadly.</p><p>4. The functional consequence of CTCL downregulation has novel implications for developmental disorders of the retina.</p><p>Weaknesses</p><p>1. While justified by realistic and pervasive limitations, all studies here are performed in human retinal organoids. The relevance of this dataset to human development in vivo is unknown. As such, all findings from this study should be interpreted with the caveat that they may represent the characterization of a humanoid model that is not directly translatable to human development and disease.</p><p>1. In the Discussion, it would be beneficial to mention Anterior segment dysgenesis 5, which is a developmental disorder of the eye associated with mutations in CTNNBIP1. This disorder is one of a collection of anterior segment dysgeneses that affect the entire anterior segment of the eye, including the cornea, iris, lens, trabecular meshwork, and Schlemm canal. This could provide more insight and context for the findings of the loss-of-function of studies.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>In the manuscript by Wang et al., the authors reported the discovery of the chimeric RNAs (chRNAs), their quantities, and categories in human retinae. Using human iPS-derived retinal organoids as a model system, they described the dynamic expression patterns of the chRNAs during development and identified certain chRNAs that are constantly expressed during the course of development studied (up to 120 days). The function of chRNAs, taking CTCL as an example, was further demonstrated by loss-of-function experiments. They demonstrated that the knockdown of CTCL led to a reduced photoreceptor population while more cells expressing RPE-specific genes are observed. Lastly, they showed that the epithelium-mesenchymal transition is the underlying mechanism for such a fate switch from photoreceptor to RPE cells. This is the first study of the role of chimeric RNAs in early retinal development. The usage of human iPS-derived retinal organoids is proper for this subject. The paper is concisely written and should be of interest to the field of developmental biology and vision research.</p><p>1) The paper for the first time revealed the landscape of chRNAs in the retina during early development. 2) The paper demonstrated that chRNAs may have important functions during neural tissue development. 3) The function of chRNAs may be tissue specific. 3) The potential mechanism of CTCL in epithelial-mesenchymal transition (EMT), an interesting mechanism involved in cell fate switches in developmental and pathological processes.</p><p>Main concerns: the evidence for EMT is solely based on RNA sequencing. The authors should at least provide the qRT-PCR verifications. A few newest pieces of literature should be cited. In the Discussion section, recent progresses in the roles of chRNAs (and the mechanisms) in tissue development and maintenance should be addressed more extensively. Their differential function in tumors and normal tissues should have been compared and distinguished in the discussion.</p><p><italic>Reviewer #3 (Recommendations for the authors):</italic></p><p>In the manuscript by Wang et al., the authors set out to profile the expression of chimeric RNAs within the retina, using human pluripotent stem cell-derived retinal organoids as the model. Chimeric RNAs are typically characterized by the inclusion of exons from different genes and as such, they have not been as extensively studied as other gene targets. However, studies have demonstrated an important role for some chimeric RNAs in both normal development as well as in some disease states such as tumorigenesis. Despite this, relatively little is known about the expression patterns of chimeric RNAs in development, including within the development of the retina. To this end, the authors have pursued approaches to address this shortcoming by using human retinal organoid models. In the study, the authors first characterize the expression of chimeric RNAs in retinal organoids at various stages of development, from undifferentiated stem cells until 120 days of differentiation, at which point many (but not all) retinal cell types are represented. To then further demonstrate the significance of these chimeric RNAs, the authors then focus their studies upon one in particular – CTCL and assess the function of this chimeric RNA in loss-of-function studies that suggest that the early expression of CTCL in retinal development predisposes tissue toward a neural retina fate rather than RPE. Taken together, the studies are presented logically and are of interest to the scientific community, but a number of issues were identified that should be addressed to assist in the clarity of the research presented as well as the reproducibility of these studies for others.</p><p>First, while the authors have published on the differentiation of retinal organoids in the past, and they discuss some features of retinal organoids at various developmental stages in this manuscript, it would strengthen the paper for the casual reader if some of this info was presented in Figure 1. For example, what is the significance of each developmental stage assessed, and how are the organoids characterized at each point? Representative immunostaining of organoids along with a description at each timepoint would greatly assist in the understanding of this study for those that are not up to date on retinal organoids.</p><p>Next, some concerns exist about the ability to reproduce these studies based on methods provided in the manuscript. For example, while the authors state that the &quot;CRX-tdTomato human ES reporter line was used for the ROs differentiation&quot;, this does not state which cell line this actually is, nor whether this is an established cell line that has been previously characterized or not. More detail needs to be provided here and if this is a new reporter line extensive characterization needs to be performed. Further, it seems that the studies were limited to the use of a single cell line, which does not take into account variability between cell lines nor between individuals, further reducing the potential impact of these results.</p><p>Next, it seems concerning that the authors &quot;examined chimeric RNAs in 22 human ROs covering eight developmental stages&quot;. While the coverage of 8 developmental stages is commendable, it seems that this suggests that an average of less than 3 retinal organoids was assessed at each developmental stage. With significant variability often observed between organoids, the use of an extremely limited number of organoids like this is further concerning, as it may not truly represent what may be found in other studies.</p><p>Some concern also exists in the experimental manipulation of CTCL in the latter parts of the paper. The authors have selected this chimeric RNA as a proof of principle based on its observed expression in their studies, as well as previous studies that have assessed this RNA in cerebral organoids. To manipulate CTCL expression the authors have used shRNA approaches to knock down expression, in which their studies demonstrate an approximately 25% reduction in expression. However, some representative images in Figure 5 suggest that most cells are not transduced, and sometimes very few are transduced. This is particularly concerning for scramble controls such as those observed in Figure 5C, where it appears that perhaps just 1 or 2 cells are transduced based upon the GFP reporter. It is not clear how much this variability affects these experiments, and the figures as presented suggest that scramble controls may not be better than untransduced cultures.</p><p>Finally, given the uncertainty around the limited numbers of organoids assessed (at least as determined by the studies as described by the authors) as well as the apparent difficulty in reproducibly transducing the organoids, it is concerning that the results presented will not be reproducible by others. While the studies are generally of interest, these shortcomings represent a concern.</p><p>To improve the manuscript, I recommend that the authors address multiple areas to improve reproducibility across studies. Either sample sizes need to be increased or if an error has been made in this review, then more effort needs to be made to describe sample sizes in the manuscript. Additional cell lines should also be used to validate these findings across subjects.</p><p>Further, I suggest justification of the studies further to create a more impactful, cohesive story. The study as it currently exists is a straightforward profiling of chimeric RNAs in the first few figures in a descriptive manner, and then an assessment of CTCL in the latter half. However, the selection of CTCL is not really based on the profiling and represents a somewhat incremental advance over previous studies in cerebral organoids. For justification in <italic>eLife</italic>, I would recommend further efforts made to integrate new findings of chimeric RNAs in retinal organoids.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.92523.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Comments to the Authors:</p><p>Weaknesses</p><p>1. Studies appear to be limited to the use of a single cell line, which does not take into account variability between cell lines or between individuals. The field standard is 3 parent lines.</p></disp-quote><p>We thank the reviewers for providing helpful suggestions which make the conclusions more solid. To prove that <italic>CTCL</italic> is not H9 cell line-specific, we assayed <italic>CTCL</italic> in naive human retinal tissues, retinal organoids cultured from five cell lines (3 human iPSCs and 2 human ESCs). Results of PCR and Sanger sequencing showed that <italic>CTCL</italic> was present in these tissues (Figure 5). More importantly, we also utilized human retinal transcriptomic sequencing data available in the GEO database to detect <italic>CTCL</italic> chimeric RNA and obtained positive results (Table 1). All of these results confirm that <italic>CTCL</italic> is not specific to the H9 cell line and that it is widely present in human retinas, organoids and cell lines.</p><disp-quote content-type="editor-comment"><p>2. While the coverage of 8 developmental stages is commendable, it seems that this suggests that an average of less than 3 retinal organoids was assessed at each developmental stage. With significant variability often observed between organoids, the use of an extremely limited number of organoids like this is further concerning.</p></disp-quote><p>We thank the reviewers for raising this concern. We actually collected a total of 22 retinal organoid samples, each containing approximately 100 organoids, and that these 22 samples covered 8 developmental stages with 2-3 biological replicates per developmental stages. We revised the context to make this clearer.</p><disp-quote content-type="editor-comment"><p>3. While the authors have published on the differentiation of retinal organoids in the past, and they discuss some features of retinal organoids at various developmental stages in this manuscript, it would strengthen the paper for the casual reader if some of this info was presented in Figure 1. For example, what is the significance of each developmental stage assessed, and how are the organoids characterized at each point? Representative immunostaining of organoids along with a description at each time point would greatly assist in the understanding of this study for those that are not up to date on retinal organoids.</p></disp-quote><p>We thank the reviewers for pointing this out. We have added relevant content to the manuscript (page5, line 96-103): On day 0 (D0) of differentiation, hESCs in a good growth state were dissociated into individual cells and seeded at a certain cell density in V-shaped low-adhesion culture dishes so that the cells would aggregate into clusters to induce the neuroepithelial formation. At D30 of differentiation, the RO outermost layer with translucent NR structures was visible. As the differentiation time prolonged, the NR gradually became denser. At D105 of differentiation, ROs could be seen with the formation of RPE. At D120 of differentiation, the outer segments of photoreceptor cells were seen on the surface of ROs.</p><disp-quote content-type="editor-comment"><p>4. Concerns exist about the ability to reproduce these studies based on methods provided in the manuscript. For example, while the authors state that the &quot;CRX-tdTomato human ES reporter line was used for the ROs differentiation&quot;, this does not state which cell line this actually is, nor whether this is an established cell line that has been previously characterized or not. More detail needs to be provided here and if this is a new reporter line extensive characterization needs to be performed.</p></disp-quote><p>We agree and have updated. We have added a description of the cell line to the manuscript (page20, line 220-224) A CRX-tdTomato reporter hPSC line was used in the <italic>CTCL</italic> knockdown experiment. This cell line is derived from H9 cells and it has been shown that tdTomato follows CRX expression spatiotemporally and the cells had the same organoid yield as H9 cells, suggesting that genetic modification of H9 did not affect its developmental process (Pan et al., 2020).</p><p>Pan, D., Xia, X. X., Zhou, H., Jin, S. Q., Lu, Y. Y., Liu, H.,... Jin, Z. B. (2020). COCO enhances the efficiency of photoreceptor precursor differentiation in early human embryonic stem cell-derived retinal organoids. Stem Cell Res Ther, 11(1), 366. https://doi.org/10.1186/s13287-020-01883-5</p><disp-quote content-type="editor-comment"><p>5. Some representative images in Figure 5 suggest that most cells are not transduced with shRNA, and sometimes very few are transduced. This is particularly concerning for scramble controls such as those observed in Figure 5C, where it appears that perhaps just 1 or 2 cells are transduced based upon the GFP reporter. It is not clear how much this variability affects these experiments, and the figures as presented suggest that scramble controls may not be better than untransduced cultures.</p></disp-quote><p>We thank the reviewers for this helpful comment. The green fluorescence in the images is captured from the live cell imaging and NOT enhanced with anti-eGFP antibodies, and as a result, the weaker green signals could not be seen in these images, but these green signals are actually visible under fluorescence microscope.</p><disp-quote content-type="editor-comment"><p>6. Evidence for EMT is solely based on RNA sequencing. The authors should at least provide the qRT-PCR verifications.</p></disp-quote><p>We performed qRT-PCR analysis of the EMT genes and the result is consistent with the RNA-seq. In the manuscript we put this result in Figure 7—figure supplement 2.</p><disp-quote content-type="editor-comment"><p>7. The Discussion section should provide greater context for the findings of the study, including recent progress in the roles of chRNAs (and the mechanisms) in tissue development and maintenance, differential functions in tumors and normal tissues should have compared and distinguished in the discussion, and relevance of loss of function studies to the retina, i.e. anterior segment dysgenesis 5 is a developmental disorder of the eye associated with mutations in CTNNBIP1.</p></disp-quote><p>Thank you for your advice. We have made such changes. The new sentence reads as follows “Advances in sequencing technology have facilitated the identification of chimeric RNAs and have stimulated the research in the field of cancer. However, researchers have also found that there are some misunderstandings about chimeric RNAs. For example, <italic>PAX3-FOXO1</italic> was initially identified as a biomarker for alveolar rhabdomyosarcoma (Singh et al., 2022), but was later found to be present during normal muscle differentiation. <italic>PAX3-FOXO1</italic> is transiently required for muscle lineage commitment (Xie et al., 2019), and can escape miR-495 regulation during muscle differentiation. If <italic>PAX3-FOXO1</italic> is not withdrawn at the right timing, it can lead to tumorigenesis. <italic>DUS4L-BCAP29</italic> was originally identified in gastric cancer, where it promotes cell proliferation and is therefore considered to have tumorigenic potential (H. P. Kim et al., 2014). <italic>DUS4L-BCAP29</italic> was subsequently identified in human non-cancerous tissues (Tang et al., 2017), and its role in promoting cell proliferation is not unique to cancer cells. It is a chimeric RNA present in normal physiology with a function in promoting neural differentiation (Tang et al., 2019). Therefore, studying chimeric RNAs in normal tissues has two implications: first, we can learn more about the normal physiological functions of chimeric RNAs; second, we can establish a control baseline for the discovery of tumor markers” and “In-frame <italic>CTCL</italic> is generated by cis-splicing fusion of the first 5 exons of <italic>CTNNBIP1</italic> and the last 17 exons of <italic>CLSTN1</italic>. The 5' parental gene <italic>CTNNBIP1</italic> encodes a receptor for β-catenin, and their binding promotes the catabolism of β-catenin, which in turn puts the Wnt pathway in an inactive state (Fu et al., 2018). Its mutation has been shown to be associated with anterior segment dysgenesis 5 in the human disease database MalaCards (https://www.malacards.org/). <italic>CLSTN1</italic> is a member of the calsyntenin family, a subset of the cadherin superfamily. It can mediate the axonal anterograde transport of certain types of vesicles (Nagase et al., 1998)”.</p></body></sub-article></article>